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ABSTRACT
This study was to determine if rats infected with Trichinella spiralis muscle 
larvae would show a rapid proliferation of antibody (Ab)-expressing B cells in the non- 
Peyer’s patch region of the small intestine, and if these B cells when compared to the 
overall B cell count were secreting multiple isotypes of Ab. AO rats were infected with 
'Trichinella spiralis muscle larvae and tissues of the small intestine, Peyer’s patch (PP), 
mesenteric lymph node (MLN), and spleen were obtained on days 1, 3, 5, 7, 10, and 15 
after infection (including the uninfected controls). The tissues were cryo-histologically 
processed, and stained with.either a pan B cell marker (0X33) conjugated with 
rhodamine (XRIT.C) or combinations of dual monoclonal Ab probes plus secondary Ab 
conjugated with XRITC or fluorescein (FITC). As compared to the uninfected controls 
(day 0), a significant increase in the number of dual Ab-expressing B cells (Debc) in the 
non-Peyer’s patch tissues of the small intestine was observed as early as day 3 with a 
maximum proliferation on days 7 and 10. B cells were also activated in the lymph 
tissues, but with delayed kinetics. In the MLN and the spleen, significant proliferation of 
Debc occurred on days 7 and 10 respectively. The non-germinal center regions of the 
Peyer’s patch (PP-NGC) showed little proliferation throughout, but a significant number 
of Debc was found as of day 10 over the controls. Within the PP-germinal centers (PP- 
GC) there were a relatively high number of Debc and single Ab-expressing B cells (Sebe) 
in the controls compared to the other tissues. As infection took place, a significant 
proliferation of Debc occurred on day 3. By adding all of the numbers of Debc 
combinations within each tissue for each of the respective days, and comparing those
iii
numbers with the total quantified number of B cells, it showed that the Debc were most 
likely expressing more than two isotypes on the surface during the peak days of 
proliferation. In the small intestine, the combined numbers of Debc were > 7 times that 
of the total number of 0X33 labeled B cells on day 7. In the lymphoid tissues, a similar 
pattern was seen. The PP-GC Debc were > 5 times higher than 0X33 labeled B cells on 
day 15, the spleen Debc were > 6 times higher than 0X33 labeled B cells on day 10, and 
the MLN Debc were > 3 time higher than 0X33 labeled B cells on day 10. In the PP- 
NGC no multiple expression was detected. The significance of this study was to show 
first that Ab-expressing B cells are proliferating in the non-Peyer’s patch region of the 
small intestine early on during infection with Trichinella spiralis, as compared to the 
surrounding lymphoid tissues. Secondly, it demonstrated that these activated B cells 
were expressing two different Ab isotypes on the surface with the possibility of multiple 
isotype expression.
iv
ACKNOWLEDGEMENTS
I would like to start by thanking ASI for their assistance in the purchase of monoclonal 
antibodies, film, and many other essential materials needed for this research to occur. I 
also want to thank IRP and CSUPERB for funding toward various presentations of my 
research throughout the past two years. Some of these presentations included 
Experimental Biology 98’ in San Francisco, and Experimental Biology 99’, in 
Washington DC. I give a lot of thanks to my advisor Dr. Ching-Hua Wang for getting 
me interested in the field of immunology, and allowing me to do research in her lab. I 
would also like to give thanks to my entire committee, Dr. Wang, Dr. Thrush, and Dr. 
Ferrari, for their patience and help in understanding various aspects of immunology and 
statistical analysis. This research was supported by Associated Students Inc. research and 
travel fund, IRP graduate students funds for professional development, CSURERB for 
professional development, and NIH grant No. AI34160-0151.
v
LIST OF ABBREVIATIONS
Abbreviation
Mesenteric Lymph Node..............................................................................  MLN
Peyer’s patch-non germinal centers........................................................................PP-NGC
Peyer’s patch-Germinal Centers................................................................................PP-GC
Dual-Expressing B Cells...............................................................................................Debc
Single-Expressing B Cells.............................................................................................Sebc
Antigen............................................................................................................................. Ag
Antibody........................................................................................................................... Ab
White Blood Cells........................................................................................................WBC
Macrophages....................................................................................................................M<(>
Polymorphonuclear cells............................................................................ PMN
Fragment, Crystalline........................................................................................................Fc
Fragment, Antigen-Binding............................................................................................ Fab
Fc Receptors...................................................................................................................FcR
Major Histocompatibility Complex.............................................................................MHC
Immunoglobulin..............;.............................................................................................. Ig
Complement...................................................................................................................... C’
Interleukin..........................................................................................................................IL
T Helper Cells...................................................................................................................Th
T Cytotoxic Cells........................  CTL
T Cell Receptor.............................................................................................................. TcR
Cluster of Differentiation.................................................................................................CD
Tumor Necrosis Factor..................................................................................................TNF
Interferon........................................................................................................................ IFN
Antigen Presenting Cells...............................................................................................APC
Thymus Dependent..........................................................................................................TD
Thymus Independent.........................................................................................................TI
Secretory Component....................................................................................................... SC
Gut-Associated Lymphoid Tissue..............................................................................GALT
Villus Crypt Unit..........................................................................................................VCU
Muscle Larvae.............................................. ML
New Borne Larvae........................................................................................................ NBL
Fluorescein isothiocyanate.................................................................... FITC
Rhodamine isothiocyanate..................................... XRITC
Analysis of Variance.............................................................................................. ANOVA
vi
TABLE OF CONTENTS
Abstract.............................................................................................................................iii
Acknowledgements........................................................................................................ .v
List of Abbreviations.........................................................................................................vi
List of Tables.............................................. ......................................................................ix
List of Figures.....................................................................................................................x
1) Introduction
1.1 Introduction to the Immune System................................................................. 1
1.2 B Cells and Antibodies.....................................................................................5
1.3 Mucosal Immunity and the Intestine............................................................... 10
1.4 Life Cycle of Trichinella spiralis...................................................................13
1.5 Purpose of This Study.....................................................................................13
2) Materials and Methods
2.1 Experimental Animals..................................................................................... 17
2.2 Infection with Trichinella spiralis Muscle Larvae..........................................17
2.3 Processing of Tissues.......................................................................................17
2.4 Immunofluorescence Staining......................................................................... 18
2.5 0X33 Staining................................................................................................. 19
2.6 Statistical Analysis..........................................................................................20
3) Results.........................................................................................................................23
3.1 Kinetics of the Appearance of Dual Ab-Expressing B Cells........................ 26
and Single Ab-Expressing B Cells in the Small Intestine
3.2 Kinetics of the Appearance of Dual Ab-Expressing B Cells........................ 36
and Single Ab-Expressing B Cells in the Spleen
3.3 Kinetics of the Appearance of Dual Ab-Expressing B Cells........................ 47
and Single Ab-Expressing B Cells in the Mesenteric Lymph Node
3.4 Kinetics of the Appearance of Dual Ab-Expressing B Cells........................ 58
and Single Ab-Expressing B Cells in the Non-Germinal
Center Region of the Peyer’s Patches
3.5 Kinetics of the Appearance of Dual Ab-Expressing B Cells........................ 69
and Single Ab-Expressing B Cells in the Germinal Center
Region of the Peyer’s Patches
vii
3.6 Kinetics of the Appearance of 0X33 Labeled B Cells.................................. 80
in the Small Intestine, Spleen, Mesenteric Lymph Node,
Peyer’s Patch-Non Germinal Center Regions, and Peyer’s 
Patch-Germinal Center Regions
4) Discussion................................................................................................ ..................90
5) Literature Cited........ ................... ............................................................................ 101
viii
LIST OF TABLES
Table 1 Numbers of Ab-Expressing B Cells in the Small Intestine........................33
Table 2 Two-Factor ANOVA Comparisons in the Small Intestine........................ 34
Table 3 Numbers of Ab-Expressing B Cells in the Spleen.....................................44
Table 4 Two-Factor ANOVA Comparisons in the Spleen..................................... 45
Table 5 Numbers of Ab-Expressing B Cells in the Mesenteric..............................55
Lymph Node
Table 6 Two-Factor ANOVA Comparisons in the Mesenteric.............................56
Lymph Node
Table 7 Numbers of Ab-Expressing B Cells in the Peyer’s Patch-.......................66
Non Germinal Center Regions
Table 8 Two-Factor ANOVA Comparisons in the Non-Germinal........................ 67
Center Regions of the Peyer’s Patches
Table 9 Number of Ab-Expressing B Cells in the Peyer’s Patch-......................... 77
Germinal Centers
Table 10 Two-Factor ANOVA Comparisons in the Germinal Center......................78
Regions of the Peyer’s Patches
Table 11 Number of CD45RA+-Expressing B Cells................................................. 88
Table 12 One-Factor ANOVA Comparisons for 0X33 Labeled B...........................89
Cells in the Small Intestine, Spleen, MLN, PP-NGC, and PP-GC
ix
LIST OF FIGURES
Figure 1 Dual-Expressing B Cells in the Small Intestine, Spleen,..........................24
MLN, PP-NGC, and PP-GC of Trichinella spiralis Infected Rats
Figure 2 Kinetics of the Appearance of IgA:IgE Dual-Expressing B......................27
Cells, IgA Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Small Intestine
Figure 3 Kinetics of the Appearance of IgM:IgE Dual-Expressing B....................28
Cells, IgM Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Small Intestine
Figure 4 Kinetics of the Appearance of IgGl :IgE Dual-Expressing B.................. 29
Cells, IgGl Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Small Intestine
Figure 5 Kinetics of the Appearance of IgG2a;IgE Dual-Expressing B................ 30
Cells, IgG2a Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Small Intestine
Figure 6 Kinetics of the Appearance of IgG2b:IgE Dual-Expressing B................ 31
Cells, IgG2b Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Small Intestine
Figure 7 Kinetics of the Appearance of IgG2c;IgE Dual-Expressing B................32
Cells, IgG2c Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Small Intestine
Figure 8 Kinetics of the Appearance of IgA:IgE Dual-Expressing B....................38
Cells, IgA Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Spleen
Figure 9 Kinetics of the Appearance of IgM:IgE Dual-Expressing B.................. 39
Cells, IgM Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Spleen
Figure 10 Kinetics of the Appearance of IgG l :IgE Dual-Expressing B..................40
Cells, IgGl Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Spleen
x
Figure 11 Kinetics of the Appearance of IgG2a:IgE Dual-Expressing B................ 41
Cells, IgG2a Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Spleen
Figure 12 Kinetics of the Appearance of IgG2b:IgE Dual-Expressing B................ 42
Cells, IgG2b Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Spleen
Figure 13 Kinetics of the Appearance of IgG2c:IgE Dual-Expressing B................ 43
Cells, IgG2c Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the Spleen
Figure 14 Kinetics of the Appearance of IgA:IgE Dual-Expressing B..................... 49
Cells, IgA Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the MLN
Figure 15 Kinetics of the Appearance of IgM:IgE Dual-Expressing B.................. 50
Cells, IgM Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the MLN
Figure 16 Kinetics of the Appearance of IgGl :IgE Dual-Expressing B................... 51
Cells, IgGl Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the MLN
Figure 17 Kinetics of the Appearance of IgG2a:IgE Dual-Expressing B................. 52
Cells, IgG2a Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the MLN
Figure 18 Kinetics of the Appearance of IgG2b:IgE Dual-Expressing B................ 53
Cells, IgG2b Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the MLN
Figure 19 Kinetics of the Appearance of IgG2c:IgE Dual-Expressing B................ 54
Cells, IgG2c Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the MLN
Figure 20 Kinetics of the Appearance of IgA:IgE Dual-Expressing B....................60
Cells, IgA Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-NGC
Figure 21 Kinetics of the Appearance of IgM:IgE Dual-Expressing B.................. 61
Cells, IgM Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-NGC
xi
Figure 22 Kinetics of the Appearance of IgG 1 :IgE Dual-Expressing B...................62
Cells, IgGl Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-NGC
Figure 23 Kinetics of the Appearance of IgG2a:IgE Dual-Expressing B................ 63
Cells, IgG2a Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-NGC
Figure 24 Kinetics of the Appearance of IgG2b:IgE Dual-Expressing B................ 64
Cells, IgG2b Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-NGC
Figure 25 Kinetics of the Appearance of IgG2c:IgE Dual-Expressing B................ 65
Cells, IgG2c Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-NGC
Figure 26 Kinetics of the Appearance of IgA:IgE Dual-Expressing B.................... 71
Cells, IgA Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-GC
Figure 27 Kinetics of the Appearance of IgM: IgE Dual-Expressing B.................. 72
Cells, IgM Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-GC
Figure 28 Kinetics of the Appearance of IgG 1 :IgE Dual-Expressing B...................73
Cells, IgGl Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-GC
Figure 29 Kinetics of the Appearance of IgG2a:IgE Dual-Expressing B................ 74
Cells, IgG2a Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-GC
Figure 30 Kinetics of the Appearance of IgG2b:IgE Dual-Expressing B................ 75
Cells, IgG2b Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-GC
Figure 31 Kinetics of the Appearance of IgG2c:IgE Dual-Expressing B................ 76
Cells, IgG2c Single-Expressing B Cells, and IgE Single- 
Expressing B Cells in the PP-GC
Figure 32 Appearance of CD45RA Positive B Cells Detected by.......................... 82
0X33 Ab in the Small Intestine of Trichinella spiralis 
Infected Rats
xii
Figure 33 Kinetics of the Appearance of CD45RA-Expressing B Cells................ 83
Detected by 0X33 monoclonal Ab Staining in the Small Intestine
Figure 34 Kinetics of the Appearance of CD45RA-Expressing B Cells................. 84
Detected by 0X33 monoclonal Ab Staining in the Spleen
Figure 35 Kinetics of the Appearance of CD45RA-Expressing B Cells................. 85
Detected by 0X33 monoclonal Ab Staining in the MLN
Figure 36 Kinetics of the Appearance of CD45RA-Expressing B Cells................. 86
Detected by 0X33 monoclonal Ab Staining in the PP-NGC '
Figure 37 Kinetics of the Appearance of CD45RA-Expressing B Cells................. 87
Detected by 0X33 monoclonal Ab Staining in the PP-GC
xiii
1) Introduction
1.1 Introduction to the Immune System:
Immune responses in the body are designed to recognize and distinguish between 
“self’ and “non-self’. It is therefore specialized not to disable cells, proteins, etc. that are 
normally found within the body, but to become activated against environmental agents 
that would be considered foreign to the body. Foreign agents could be organisms such as 
bacteria, viruses, and parasites that contain antigens (Ag) which trigger host immune 
responses. Cells of the immune system are only found in vertebrates, and develop from 
pluripotential stem cells in the bone marrow, fetal liver, and fetal spleen tissue as 
reviewed by Benjamini et al. (1996). These cells are separated into five general classes 
of white blood cells (WBC) being either specific or nonspecific against any potential Ag.
WBC are located throughout the body in nearly all organs and tissues, including 
brain, liver, and skin. Some tissues, under normal physiological conditions, have higher 
numbers of WBC such as the spleen, bone marrow, thymus, and various lymph tissues. 
WBC consist of neutrophils, basophils (mast cells in the tissues), eosinophils, monocytes 
[macrophages (M<()) in the tissues], and lymphocytes (B cells, T cells, and null cells). 
Neutrophils, basophils, and eosinophils are referred to as polymorphonuclear (PMN) 
granulocytes because of the multi-lobed nucleus and the large number of intracellular 
granules that contain many hydrolytic enzymes that are released toward the invading 
organism when the PMN cells become activated. Neutrophils are generally short-lived, 
nonspecific, and phagocytic cells that engulf an organism that it contacts. Phagocytosis 
in eosinophils is very uncommon, and in basophils is non-existent. PMN have the ability
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to interact with an organism that has bourid antibodies (Ab). On a cell surface, the Ab 
produced by B cells can then bind to Fc receptors (FcR) on PMN cells. Among the most 
common FcR in PMN cells are FcyR (Ravetch et al., 1991; Unkeless et al., 1988) specific
for IgG Ab, and FcsR (Takizawa et al., 1992; Shaikh et al., 1997) specific for IgE Ab. 
Once the PMN binds to the cell-bound Ab, degranulation occurs. These granules then 
attack cells nonspecifically and cause a leaking out of intracellular components, and cell 
death. Unlike M<|), PMN cells are short lived, and do not usually act in Ag-presentation 
to T cells. Gosselin et al. (1993) though did suggest using an in vitro human cell line, 
that neutrophils could be induced to express MHC class II molecules and could therefore 
play a significant role in immunoregulation and pathogenesis of disease. This type of 
study has yet to be shown though during an in vivo response.
M(J) are similar to PMN cells by being phagocytic and nonspecific as to the
organism it engulfs. M<(),are specialized for phagocytizing foreign agents, foreign cells, 
particulate material, and/or dying cells that are present in the body. These are 
mononuclear cells that are considered long lived when compared.to PMN life spans of 1 
to 2 days (Bainton et al., 1971). This longer life span allows for.the differentiation of 
monocytes in different tissues. Some of these include Kupffer cells in the liver (Naito et 
al., 1997), osteoclasts in bone (Quinn et al., 1996), alveolar cells in the lungs (Higashi et 
al., 1992), and dendritic cells in the spleen and other lymph tissues.
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M<|) can use FcyR on its surface to bind to IgG, that have specifically bound to an
Ag (ex. foreign cells) (Ravetch, 1991). M(|) also have the capability of expressing 
complement (C’) receptors on its surface which can bind C’-coated particles and lead to 
eventual phagocytosis, a process known as opsonization.
The invading organism that comes into contact with the M<j) is phagocytized,
becoming encased in a vesicle called a phagosome, that undergoes a fusion with 
lysosomes. The lysosomal enzymes then break down the organism into small particles. 
These particles (i.e. Ag) can be expressed along with the major histocompatibility 
complex (MHC) class I and class II molecules on the surface of the M<j). Once the M(j) is 
activated, it is able to secrete cytokines like interleukin-1 (IL-1) (Hilbi et al., 1997), IL-6 
(Ghaffar et al., 1998), IL-12 (Muller et al., 1997), and tumor necrosis factor a (TNFa)
(MacDermott, 1996). Some of these cytokines then lead to activation of T cells and B 
cells that make up the specific immune defense.
T cells make up the cell-mediated immunity and consist of several major cell 
types including CD4 + T helper cells (Th), CD4+ delayed type hypersensitivity (Tdth) 
cells, and CD8+ T cytotoxic cells (CTL). After being produced in the bone marrow, the T 
cells migrate to the thymus to become fully differentiated. Mature T cells migrate to the 
peripheral lymphoid tissues and are able to respond to Ag. To become activated, an Ag 
must be presented to the T cell in association with the MHC molecule. MHC molecules 
consist of two types, class I MHC, and class II MHC. Class I MHC molecules are 
expressed on virtually all cell types where as class II MHC molecules are limited to only 
a few cell types including B cells, T cells, and M<j) (Sprent, 1993). T cells express T cell
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receptors (TcR) that recognize and bind to MHC molecule only when processed Ag is 
being presented with the MHC molecule on the surface of the cell. Upon TcR-Ag-MHC 
binding, either CD4 or CD8 molecules of T cells will extend out and bind to a 
nonpolymorphic site on the MHC molecule to strengthen the interaction (Sprent, 1991). 
Using CD3, a signal transduction molecule closely associated with the TcR, a signal 
enters the T cell and leads to T cell activation (Hedrick et al., 1993).
CD8+ cytotoxic T lymphocytes (CTL) bind specifically to processed Ag presented 
by MHC class I molecule, and when activated they bring about cytolysis and cell death of 
the “target” (von Boehmer, 1988). Specific targets of these killer lymphocytes are 
principally host cells infected with intracellular microorganisms such as viruses, certain 
bacteria, and some cancerous cells (Berke, 1997). CTL act mainly under the control of 
CD4 T helper cells and the cytokines these cells produce. A CTL is activated by 1) TcR- 
Ag-MHC II complex, 2) CD28-B7 interaction, and 3) the CD4 T helper cells which then 
secrete IL-2, IL-12, and ylFN among others. The CTL will then differentiate, proliferate,
produce memory cells, and cause lysis of the target cell.
CD4+ helper T cells act as the major regulatory cells of the immune system.
These cells recognize processed Ag presented by MHC class II molecule via the TcR, 
and are specialized to react with Ag derived from extracellular sources (Fitch et al.,
1993). When CD4 cells become activated, cytokines are secreted to allow for a wide 
variety of immune responses. CD4 T helper cells are generally broken into two subsets,
T helper 1 (Thl) and T helper'2 (Th2), depending on their functional capabilities and
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cytokines they produce. The Thl subset secretes cytokines such as ylFN, TNF, and IL-2, 
which are usually associated with inflammation, and cell-mediated immune responses 
(Constant et al., 1997). The Th2 subset produces cytokines such as IL-4 and IL-5 that 
help B cells to proliferate and differentiate and is associated with humoral-immunity 
(Constant et al., 1997).
1.2 B Cells and Antibodies:
B cells are a central part of the humoral immune response that includes 
production of antibody (Ab) to interact with a specific epitope on an Ag. B cells express 
MHC class I and class II molecules on the surface so they maintain the capability of 
being an Ag-presenting cell (APC), to T cells. The main function of B cells is to produce
and secrete Ab.
Ab, also known as immunoglobulins (Ig), are glycosylated proteins that function 
1) to neutralize an Ag, 2) opsonization, 3) antibody-dependent cell cytotoxicity (ADCC), 
and 4) C’ activation. The basic structure of an Ab includes two identical heavy chains 
and two identical light chains held together by disulfide bonds. An Ab can be 
enzymatically cleaved into two main fragments of these four polypeptide chains, the Fab 
and the Fc fragments. The Fab fragments are responsible for Ag binding. TheFc 
fragments function in binding to phagocytic cells via the FcR, activation of C’, and also 
can mediate other biological activities.
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Each chain (both heavy and light) has two regions, the constant and the variable. 
Within the variable region are several hypervariable regions that actually form the 
binding site for an Ag. It is this variability of sequences of amino acids that provides the 
diversity in the Ag binding site. Connected to the variable region is the constant region 
on both the heavy and light chains. The constant region of the heavy chain is important 
in determining the biological function of different Ab and their isotypes. Ab isotypes 
consist of IgM, IgD, IgA, IgG, and IgE, which allow for response to various types of 
pathogens.
During B cell development, IgM and IgD are found first on the B cell surface. 
Little is known about the function of IgD, either membrane-bound or in the serum. 
However, what is known is that it is present in low quantities and has a short half-life. 
IgM is the first Ab produced in primary immune responses, which leads to activation of 
naive B cells. IgM is also a surface marker for both immature and mature B cells 
(Carayannopoulos et al., 1993). When secreted into the serum, IgM becomes a pentamer 
that is joined together by a polypeptide called a J chain. When bound to microorganisms, 
IgM leads to C’ activation (Wright et al., 1990) and thus Ag destruction.
IgG is the most well studied isotype and is the predominant immunoglobulin in 
the blood, and lymph fluid making up to 70-75% of Ab molecules produced in the serum. 
There are generally four subclasses designated IgGl, IgG2, IgG3, IgG4 in humans; IgGl, 
IgG2a, IgG2b, IgG3 in mice; IgGl, IgG2a, IgG2b, IgG2c in rats (Snapper et al., 1993). 
Although IgG is produced in a primary immune response, it is the major Ab produced in
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secondary immune responses. IgG is produced by memory B cells in a secondary 
immune response, which is a much quicker response than primary immune responses. 
IgG is also important in Ag neutralization, ADCC, and also C’ activation.
The final two isotypes are IgA that is expressed mainly in mucosal sites, and IgE 
that is important in parasitic infections and allergic reactions. IgA is present mostly as a 
dimer with a primary function against local infections in the intestine, respiratory tract, 
and other mucosal tissues. IgA is also produced in the highest amount in the body with . 
5-15g being secreted in mucous per day as reviewed by Kuby (1997). There is usually 
more IgA-producing B cells within the intestine than total Ab-producing B cells in the 
spleen, lymph nodes, and bone itiarrow combined (Lamm, 1997). Under normal 
circumstances, IgE is present in the serum at the lowest concentration of all Ab isotypes, 
and it is important for protection against certain microorganisms and is also involved in 
certain allergic responses. IgE binds with high affinity to the FcsR on mast cells, 
basophils, and with low affinity to eosinophils, to lead to degranulation and an 
inflammatory response.
B cells originate in the bone marrow from progenitor hemopoietic stem cells that 
lead to the production of pro-B cells arid the beginning of Ab gene rearrangement. The 
production of Ig components plays an important signaling role in guiding the initial 
stages of B cell differentiation (Tough et al., 1995). From pro-B cells to pre-B cells 
arrangement of the heavy chain is completed with the expression of a CM (leads to IgM 
heavy chain expression). DNA recombination of a diversity (D) gene with a joining (J) 
segment starts this process. The D region is then linked to a variable (V) gene, and
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finally the J segment binds to the constant (C) region gene that contains the genes to 
express all of the possible isotypes. There are about 100 possibilities for V, 50 for D, and 
6 for J genes for each human Ab. The random rearrangement is one of the reasons for 
such diversity among Ab specificity toward an Ag. Once the heavy chain gene 
rearrangement takes place, specific B cell lines can only produce immunoglobulins of 
one antigenic specificity. The next step in development is that from pre-B cell to 
immature B cell, and this is the point where the light chains are produced. IgM is then 
expressed on the surface of the B cell. Light chains do not have a D segment, and the C 
segment is limited to either A, or k. After successful rearrangement of one of the light
chain genes, the B cell is considered mature, expressing both IgM and IgD on the surface, 
and awaiting to be activated by a specific Ag.
B cell activation by an Ag proceeds in two possible routes, a T cell dependent 
(TD) pathway or a T cell independent (TI) pathway. Activation by TD Ag involves a 
complex interaction between B cells and Th cells. The surface Ab of a B cell first binds 
to the Ag and the B cell then internalizes the Ab-Ag complex and processes the Ag for 
MHC II expression. TcR are now able to link to the processed Ag on the MHC II 
because the B cell is now acting as an APC. A CD40 molecule on the B cell also binds to 
a CD40L on the T cell, which in turn stimulates expression of cytokine receptors on the B 
cell. This interaction between CD40 and CD40L is necessary for the initiation of the last 
phase of B cell development (Klein et al., 1997). This last phase includes the production
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of plasma cells for Ab secretion, isotype switching, and production of memory cells for a 
more rapid secondary response to the specific Ag in the future. In this process, M<j) can 
also act as APC. Together with Th cells, they can activate B cells specific for a TD Ag.
B cells can respond to Ag without the help of Th cells though only few B cells use 
this pathway. Examples of TI Ag are lipopolysaccharides (LPS) and other 
polysaccharides that have multiple repeating units that are often found on bacterial cell 
walls. These Ag cause cross-linking of surface Ab on a B cell and therefore mobilize Ab 
toward one specific region on the B cell membrane. This process is referred to as 
“patching” and “capping”. The B cell internalizes the Ab-Ag complex via receptor- 
mediated endocytosis, becomes activated, and leads to proliferation and Ig secretion. B 
cells activated in this manner typically produce only IgM, and they do not give rise to 
memory cells. This means that a TI reaction will always give a primary response to its 
specific Ag, where as the TD response can produce memory cells for a much more rapid 
secondary response to a particular Ag.
Once activated, B cells have the capability of undergoing a process called isotype 
switching. Isotype switching allows for the Ab to keep its specificity while generating a 
more extensive immune response. A general model for this process involves a further 
rearrangement of the heavy chain DNA in which the VD J unit can combine with any C 
gene segment (Chen et al., 1993). Between each C segment there is a region referred to 
as a switch site (S), which allows the DNA strand to loop around and connect to the SM 
site. All C segments between the Cg and the selected C segment are then excised out of 
the DNA strand and the new isotype is expressed. Because of the DNA recombination
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and deletion, the B cell’s genome will no longer contain the deleted C segments and 
therefore are no longer able to express other isotypes of Ab. An alternative approach to 
isotype switching involves a similar process, but differential RNA splicing occurs after 
transcription (within the RNA strand). This RNA splicing process allows the B cell to 
maintain its entire C region at the DNA level. Therefore the B cells are still able to 
express other Ab iso types through production of new RNA strands. It is important to 
note that because Ab specificity is determined by the variable region of Ab, class 
switching does not change the Ag-binding specificity (Stavnezer, 1996).
Isotype switching is commonly stimulated by various cytokines that are produced 
by T cells. Th cells produce the cytokines that help activate the B cells. Some cytokines 
such as IL-4 stimulates production of IgG and IgE, IFN-y stimulates increased levels of
IgG2a and IgG3, and TGF-(3 stimulates increased levels of IgG2b and IgA (Morawetz et 
al., 1996).
1.3 Mucosal Immunity and the Intestine:
The linings of the mucosal tissues have the largest surface area of any part of the 
body (Mowat et al., 1997). Mucosal tissues include the gastrointestinal (GI) tract, upper 
and lower respiratory tracts, urogenital tract, and oral cavity. Mucosal tissues consist of 
the outer epithelium and the inner connective tissue lamina propria. Mucosal epithelium 
of the GI tract contains columnar absorptive cells, Paneth cells, goblet cells, tuft cells, 
cup cells, enteroendocrine cells, undifferentiated crypt epithelial cells, and intraepithelial 
lymphocytes, all of which are important for absorption of nutrients and/or protection of
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the GI mucosa. Within the lamina propria there are various immunocompetent cells 
including M<)>, dendritic cells, and lymphocytes that help to prevent the further entrance 
of pathogens into the body.
The cells lining the mucosa are constantly being exposed to pathogens, including 
viruses, bacteria, and multi-cellular parasites. Thus, it is due to this constant 
bombardment of pathogens that vertebrates developed a mucosal immune system. This 
developed host defense includes barriers against potential pathogens such as GI acidity, a 
thick mucous membrane, and the various cells involved in immune responses. The cells 
of the mucosal immune system work the same way as those in other non-mucosal tissues, 
except that most immunity tends to be localized within mucosal tissues rather than
systemic. APC, including B cells, M<(), dendritic cells, and epithelial cells (Kaiserlian et 
al., 1989) process Ag, express the processed Ag on MHC II, and activate Th cells. 
Activation of TIB cell and CTL cells does occur, although in much lower frequencies.
Activation of the Th cells locally lead to activation and proliferation of B cells, 
which produce mucosal responses to pathogens. IgA, produced and secreted by B cells, 
are the major Ab produced in mucosal secretions (Klein et al., 1997; Ogra et al., 1994). 
After secretions of IgA from the B cells, IgA becomes dimeric by acquiring a J chain and 
a secretory component (SC) as it passes through mucosal epithelial cells into the lumen. 
Once in the lumen, SIgA binds and neutralizes potential pathogens before they enter the 
body through the mucosal tissues. Although IgA is the major Ab found in mucosal 
regions, other classes of Ab, such as IgM, IgG, and IgE, can also be present in mucosal 
tissues, depending on the infectious pathogen (Lamm, 1997; Mestecky et al., 1999).
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Among the best-studied mucosal immune tissues are the gut associated lymphoid 
tissues (GALT) of the GI tract. GALT comprises the Peyer’s patch (PP), mesenteric 
lymph nodes (MLN), and a large number of lymphocytes throughout the lamina propria 
and epithelium of the intestine (Mowat et al., 1997). One of the major functions of 
GALT is the elaboration of B cells and in particular IgA-producing B cells, which have 
been well studied within this region (Kawanishi et al., 1983a; McIntyre and Strober, 
1999).
PP is a secondary lymphoid tissue that is located in the submucosal lining of the 
intestine. Within the PP are regions called germinal centers, from which B-lymphocytes 
are able to mature into plasma cells and undergo class-switching from IgM to IgA and 
also other Ab classes like IgG (Weinstein and Cebra, 1991). The non-PP regions of the 
intestine where lymphocytes reside are structured as villus crypt units (VCU), which 
consist of the epithelium and lamina propria tissues. Within this tissue are also several 
different cells of the immune system such as B cells, T cells, and dendritic cells. A major 
feature of the B cells are that most have already differentiated into plasma cells and are 
therefore instantly available for response to infection. Draining the lymph from these two 
areas of the intestine is the MLN that harbors lymphocytes and M<(>, which can further 
drain into the blood stream for systemic circulation. This would allow protection for the 
rest of the body to potential pathogens that may infect elsewhere.
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1.4 Life Cycle of Trichinella spiralis'.
A well-known parasite Trichinella spiralis is able to infect the epithelial layer of
t
the intestine in all mammals. As dogs, swine, rodents, or humans ingest meat infected 
with Trichinella spiralis, the Trichinella spiralis muscle larvae (ML) are able to survive 
and infect its new host (Hickman et al., 1984). Ingested ML enter the intestinal 
epithelium and undergo four molts to become adult worms (Pond et al., 1989). Here the 
adult worms mate and produce newborn larvae (NBL) that migrate through the lymph 
nodes and into the bloodstream and lymph. These NBL will eventually reach muscle 
tissues where they will bury in coiled position and form cysts (Ritterson, 1966; Wang et 
al., 1987). Trichinella spiralis now encysted within the muscle tissue can reside there for 
the life of the host or if ingested result in infection of a new mammal.
1.5 Purpose of This Study:
Intestinal immune responses have been well characterized against various 
infectious parasites such as Nippostrongylus brasiliensis (el-Hag et al., 1989), Trichuris 
muris (Grencis, 1993), Trichinella pseudospiralis (Wakelin et al., 1994), and Trichinella 
spiralis (Wakelin et al., 1994; Ishikawa et al., 1997). Infection with Trichinella spiralis 
muscle larvae has been extensively studied due to its specific infection within the 
epithelial layer of the small intestine. This infection leads to active immune responses by 
both T cells and B cells that can lead to the eventual expulsion of the pathogen. Most B 
cell research involving intestinal pathogens has revolved around IgA production in the 
Peyer’s patches (Spencer et al., 1986; Jeska et al., 1989); Trichinella spiralis research is,
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only recently, turning to other nonlymphoid intestinal regions and investigating the 
possibility of other isotypes of Ab being produced. T cell responses to intestinal 
helminthic infections are primarily Th cells, and specifically from Th2 (Grencis, 1997;
Ishikawa et al., 1997; Wang et al., 1990).
Wang et al. (1990) showed that 0X22' (Th2) T cells led to eosinopoiesis against 
Trichinella spiralis in the intestine, and there was a rapid proliferation of Th2 cells within 
12hrs of Trichinella spiralis infection. The fact that Th2 cells produce cytokines like IL- 
4 and IL-5 would suggest a wider range of isotypes of Ab (other than IgA) being 
produced by B cells against this pathogen. This is due to IL-4 being responsible for the 
production of IgE, among other Ab isotypes, while IL-5 enhances eosinophilia (Hamada 
et al., 1992). Previous studies have shown that Trichinella spiralis infected rats transport 
IgE from the plasma to intestinal tissue (Negrao-Correa et al., 1996). Wang et al. (1998) 
have shown elevated production of all major Ab isotypes by B cells, and more recently 
(Wang et al., 1999) a particularly high increase in IgE and IgGl in the intestine of rats 
infected with Trichinella spiralis.
There are five Ab isotypes and in principle, the higher diversity of isotypes of Ab 
secreted by B cells will result in a stronger and broader spectrum of protection that is 
generated in the host. The results produced from Wang et al. (1998, and 1999) showed 
the possibility that B cells may be capable of producing more than one Ab isotype on its 
surface at a given time towards the Trichinella spiralis Ag. This observation is based on 
the overwhelming number of Ab-producing B cells counted per villus crypt unit in this 
study, and also because all of the Ab isotypes were found to be expressed by B cells
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throughout. Few studies have dealt with the possibility of multiple isotype expression by 
B cells (Fujieda et al., 1996; Shimizu et al., 1991; Goodman et al., 1997; Nolan-Willard 
et al., 1992), and none of these studies were reproduced in vivo. Rather most studies 
involving the production of multiple Ab isotypes by B cells have been in vitro, using 
various cell lines. Most investigations of an immune response by B cells producing 
multiple Ab isOtypes were in lymphoid tissue as well, and involved limited variations 
within the different isotypes being expressed. The experiments described in this thesis 
were designed to determine first whether there was rapid proliferation of Ab-producing B 
cells in the nOn-Peyer’s patch region of the small intestine in rats infected with 
Trichinella spiralis muscle larvae. Secondly, the study examined whether these B cells 
expressed multiple isotypes of Ab at a given time. The isotypes of each specific Ab 
isotype for IgA, IgM, IgGa, IgG2a, IgG2b, and IgG2c was identified by a fluorescent 
marker (fluorescein), and then B cells were viewed using a second fluorescent marker 
(rhodamine) specific for IgE to determine if multiple Ab were expressed. Following this 
procedure the total number of B cells were quantified using a pan B cell marker, 0X33 
monoclonal Ab, that labels CD45RA found only on B cells in rats (PharMingen, 1998). 
This CD45 isoform is found on all pre-B cells, immature, mature, and activated B cells.
B cells expressing various Ab isotypes were examined in Peyer’s patches for germinal 
center and non-germinal center regions, mesenteric lymph node, spleen, and a 
nonlymphoid region of the small intestine. The data obtained from these experiments are 
presented in this thesis and they demonstrate that intestinal B cells are indeed activated 
rapidly during the early stage of infection with Trichinella spiralis. Moreover, these B
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cells are able to produce at least two, and most likely more than two, Ab isotypes upon 
activation. This study is the first of its kind to provide definite evidence of co-expression 
of multiple Ab isotypes by activated B cells in the gut-associated lymphoid tissues 
against a parasitic pathogen during an early stage of a natural infection.
16
2) Materials and Methods
2.1 Experimental Animals:
Male or female pathogen-free AO rats of six to eight weeks of age were 
randomized into seven groups of six to conduct this experiment. Rats were purchased 
from Harlan-Sprague Dawley (Indianapolis, In), and maintained at the California State 
University San Bernardino vivarium where food and water were distributed ad libitum.
2.2 Infection with Trichinella spiralis Muscle Larvae:
Muscle larvae from infected rats were isolated by digesting minced rat carcasses
with 1% pepsin hydrochloride at 37 °C for 1 hr. The digested fluid was first filtered 
through cheesecloth to remove bones and undigested tissues, and then filtered through a 
200 - mesh sieve using 0.85% NaCl to retain the larvae. Muscle larvae were then 
counted and the concentration adjusted accordingly. Infection was carried out by 
injecting 2,000 muscle larvae per rat orally using a blunt end feeding needle.
2.3 Processing of Tissues:
Tissues from the small intestine (15 cm distal from the pylorus), Peyer’s patch 
(nearest to the portion taken from the intestine), mesenteric lymph node, and spleen were 
obtained from both control (day 0) and infected rats. Tissues of rats infected with the 
Trichinella spiralis muscle larvae were collected on days 1, 3, 5, 7, 10, and 15. Tissues 
were cryo-histologically processed using a snap-freezing technique (Lincoln et al., 1998). 
Described briefly, tissues were immersed in isopentane (cooled in liquid nitrogen) for 10
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sec, and then added along with Histo Prep tissue embedding media (Fisher Scientific, 
Pittsburg, Pa:) to an aluminum foil cup. Tissue were then frozen and stored at - 80 °C
until further processing. Each of the frozen tissues was cut into 6pm sections using a Lab 
Tek Precision Microtome Cryostat (Lab Tek Instruments Co., Westmont, IL.). The tissue 
sections were then placed on slides coated with Poly-L-lysine, and allowed to air diy. 
Slides were then fixed in 2% paraformaldehyde at room temperature for 20 min, and 
finally washed three times in IX PBS pH 7.2 (5 min each wash).
2.4 Immunofluorescence Staining:
A double-labeling immunofluorescence assay was used in order to show the 
different isotypes of antibodies expressed by B cells located within the tissues. All 
antibody probes were purchased from Accurate Chemicals and Scientific Corp. 
(Westbury, NY.), or Zymed Labs Inc. (San Francisco, CA). The optimal dilution of each 
of the antibody probes has been previously determined (Wang et al., 1998). Each tissue 
section was stained for 1 hr at room temperature with 20 pL per section of 1:500 diluted 
monoclonal mouse anti-rat IgA, IgM, IgGl, IgG2a, IgG2b, or IgG2c, respectively. 
Following incubation, this primary antibody was aspirated off, and slides washed three 
times in IX PBS pH 7.2 for 5 min. Then 20 pL of fluorescein isothiocyanate (FITC) 
conjugated goat anti-mouse Ig [F(ab)2’], and goat anti-rat IgE labeled with rhodamine 
isothiocyanate (XRITC) [F(ab)25] were added to each slide in a 1:1000 dilution and 
mixed together in a 1:1 ratio. These Ab were H chain specific and in the F(ab)2’ form to 
prevent non-specific binding to the Fc receptors. Normal rat serum was used at a dilution
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of 0.1 % in the antibody preparation to prevent non-specific binding. FITC conjugated 
antibody stained the mouse antibody isotypes green, and the XRITC conjugated antibody 
specifically shows a red color when bound to IgE producing B cells. This fluorescence 
staining was taken under dark conditions at room temperature for 1 hr. Slides were once 
again washed three times in IX PBS pH 7.2 for 5 min. Each slide was then mounted with 
fluorosave to prolong the staining effect, and then coverslips added. Antibody labeled B 
cells were viewed using a Nikon Optiphot Biological Microscope with an Episcopic- 
Fluorescence attachment EF-D containing a B2A 495nm filter specific for viewing FITC, 
and a G2A 546nm filter specific for viewing XRITC. Single and double-labeled cells of 
at least 10-20 villus crypt units (VCU) per intestine and 10-20 fields (400X) per section 
for spleen, Peyer’s patch, and mesenteric lymph node were counted visually for each rat.
2.5 0X33 Staining:
0X33 is a monoclonal antibody that identifies a pan-B cell marker, CD45, on rat
B cells (0X33 is a gift from Oxford University to Dr. Ching-Hua Wang). This antibody 
has been conjugated with XRITC in this laboratory. After staining with this antibody 
probe, the overall number of B cells in each of the four tissues in infected versus control 
rats, were enumerated. Each tissue section was cut similar to that described above,
placed on the Poly-L-lysine coated slides, fixed with 100% acetone at -20 °C for 2 min, 
and washed three times in IX PBS pH 7.2 for 5 min. In order to determine the optimal 
staining conditions, several slides were stained with different dilutions of mouse anti-rat 
0X33 monoclonal antibody labeled with XRITC for lhr at room temperature to
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determine optimal staining. The 0X33 was then aspirated off and washed three times 
with IX PBS pH 7.2 for 5 min. Once an optimal dilution was determined, then slides for 
each tissue and day of infection were stained and washed in the same manner. Overall B 
cell numbers were counted visually using the fluorescent microscope as described 
previously.
2.6 Statistical Analysis:
Data were analyzed using Microsoft Excel 97. Tools used from this program 
included a one-factor analysis of variance (ANO VA) for determination of differences in 
OX33-labeled B cells, and two-factor ANOVA with replication for determination of 
differences between different dual Ab-expressing B cell (Debc) combinations and also 
the differences between Debc and the respective single Ab-expressing B cells (Sebc). 
Effects that resulted in a significant F value were then subjected to Student-Newman 
Keuls multiple range tests for determination of significant differences between groups. 
Student-Newman Keuls tests were calculated using equations from Statistical Methods 
(Snedecor and Cochran, 1980).
Forty-two rats were infected with Trichinella spiralis on day 0. Six rats were 
sacrificed on days 1,3, 5, 7, 10, and 15 post infection. Six uninfected rats were sacrificed 
on day 0 to act as controls. On each of the sample days tissues from the small intestine, 
spleen, MLN, and PP were obtained from each rat. One slide carrying 3-5 tissue sections 
was prepared for each tissue from each rat. Dual and single Ab-expressing B cells form 
each of the tissues were counted on each slide, and the means of 20 fields (villi in the
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small intestine) at 400X magnification were calculated for each rat. The mean value 
from the 20 fields (or villi) for each rat was then used to determine the group means of 
Ab-expressing B cell proliferation for different combinations of Debc, or between Debc 
and Sebc. These values were analyzed using ANOVA.
The day specific means of different dual-Ab expressing B cell combinations were 
compared using a two-factor ANOVA with day and dual-Ab combination as fixed 
effects. In this analysis a significant day effect would indicate different levels of dual 
Ab-expressing B cell proliferation over the course of the infection. A significant dual 
Ab-expressing B cell effect would indicate that there were differences in the level of 
expression of the different dual Ab-labeled B cell combinations. Effects resulting in 
significant F values from the two-way ANOVA were then subjected to a Student- 
Newman Keuls test to determine any significant differences between cell means. Values 
of q with p<0.05 were considered significant.
The day specific means of Debc and Sebc were compared using a two-factor 
ANOVA with day and Ab-expression by B cells as fixed effects. The purpose of this 
analysis was to determine if there were any differences between Ig_:IgE-Debc, Ig_-Sebc, 
and IgE-Sebc within each day of infection. In this analysis a significant day effect would 
indicate different levels of Ab-expressing B cell proliferation over the course of the 
infection. A significant Ab-expression effect would indicate that there were differences 
in the level of expression of the different Ab-expressing B cell combinations. Values
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resulting in significant F values were then subjected to a Student-Newman Keuls test to 
determine any significant differences between cell means. Values of q with p<0.05 were 
considered significant.
The means of OX33-Ab data were compared using a one-factor ANOVA for each 
tissue tested, with day as a fixed effect. The CD45RA+ B cells were labeled with 0X33- 
Ab, and this gave a general idea of the total number of B cells within each tissue for 
respective days post infection. The one-factor ANOVA determined if there was a 
difference in the total number of CD45RA+ B cells on different days post-infection with 
Trichinella spiralis. If the day effect was significant, day means were then subjected to a 
Student-Newman Keuls test to determine which days differed. Values of q with p<0.05 
were considered significant.
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3) Results
To determine the expression of Ab by B cells, AO rats were infected with 2,000 
Trichinella spiralis muscle larvae on day 0 of infection. Rats were randomly assorted 
into seven groups of six rats and tissues were taken from the small intestine 15cm distal 
to the pylorus, the Peyer’s patches, mesenteric lymph node, and the spleen on days 0 
(control), 1, 3, 5, 7, 10, and 15 of infection. Tissues were cryo-histologically processed 
and then labeled with monoclonal mouse anti-rat IgA, IgM, IgGl, IgG2a, IgG2b, or 
IgG2c Ab respectively, followed by FITC-conjugated goat anti-mouse Ig- and XRITC- 
conjugated goat anti-rat IgE Ab in a 1:1 ratio. The appearance of Ab-expressing B cells 
were quantified as either single expressing B cells (Sebc) or dual expressing B cells 
(Debc) by immunofluorescence microscopy. B cells expressing IgE appeared bright-red 
when using a 546nm filter, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c expressing 
B cells appeared bright-green when using the 495nm filter. Figure 1 shows the color 
signals that are produced by this fluorescence labeling technique. The photographs are of 
samples from the small intestine on day 7, spleen, MLN, PP-NGC, and PP-GC on day 10 
of infection. In Figure 1 (A, C, E, G, and I), FITC-labeled IgGl-expressing B cells are 
shown to be localized within a field or villus crypt unit (VCU) in the small intestine using 
a 495nm filter. In Figure 1 (B, D, F, H, and J), the above B cells that also express IgE are 
bound by the XRITC conjugated goat anti-rat IgE Ab and are visible by
immunofluorescence microscopy using a 546nm filter.
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Fig. 1 Dual-Expressing B Cells in the Small Intestine, Spleen, MLN, PP-NGC, and 
PP-GC of Trichinella spiralis Infected Rats
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Fig 1 Contd.
G. H.
Fig. 1 Dual-Expressing B Cells in the Small Intestine, Spleen, MLN, PP-NGC, and 
PP-GC of Trichinella spiralis Infected Rats: Tissues were labeled with monoclonal 
mouse-anti-rat IgGl Ab, and FITC-conjugated goat-anti-mouse IgG [H&L chain specific 
(F(ab)2J fragment)]: XRITC-conjugated goat-anti-rat IgE Ab [H chain specific (F(ab)2’ 
fragment)] in a 1:1 ratio. (A, C, E, G, I) IgGl-expressing B cells localized within a field 
[villus crypt unit (VCU) in the small intestine] as observed @ 400X magnification using 
a 495nm filter specific for viewing FITC. (B, D, F, H, J) IgE-expressing B cells localized 
within the identical villus crypt unit (VCU) as observed @ 400X magnification using a 
546nm filter specific for viewing XRITC. (A, B) Small intestine; (C, D) spleen; (E, F) 
MLN; (G, H) PP-NGC; (I, J) PP-GC. The intestinal tissue was obtained on day 7, and 
the other tissues were obtained on day 10. The diameters of the labeled cells are between 
10-12pm.
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3.1 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single Ab-
Expressing B Cells in the Small Intestine:
Intestinal samples labeled with specific monoclonal mouse anti-rat IgA, IgM,
IgGl, IgG2a, IgG2b, and IgG2c Ab respectively, and goat anti-rat IgE Ab showed a 
significant increase in the number of double-labeled B cells per VCU by day 3 of 
infection (Fig.. 2-7). This significance was maintained for the remainder of the experiment 
as compared to the day 0 controls. There were no significant differences for different 
dual Ab-combinations between respective days of infection throughout the duration of 
the experiment. The number of IgAilgE dual-expressing B cells (Debc) (Fig. 2) showed 
a significant increase on average per villus by day 3 (3.4+1.15), with a maximum on day
7 (28.13±3.52) compared to the controls (0.30±0.45). On day 0 IgMTgE-Debc in the
small intestine were less than (0.08±0.11) that of IgM single expressing B cells (Sebc)
(0.23±0.14) on average per villus (Fig. 3), although the differences were not significant. 
IgMTgE-Debc were significantly increased in number as of day 3 of infection
(3.83±2.02) with the highest number of B cells per villus detected on day 7 (26.32+8.2)
and day 10 (24.15+4.61) (Fig. 3). IgGl TgE-Debc showed the greatest amount of dual-
Ab expressing B cells per villus with day 7 (28.53+3.26) and day 10 (29.01±3.87) being 
the peak days of infection (Fig. 4). A significant increase over the day 0 (0.21+0.18) 
occurred after day 3 of infection (3.79+3.87) (Fig. 4). IgE:IgG2a, IgE:IgG2b, and 
IgE:IgG2c-Debc also showed similar significant increases in quantity from day 3 of 
infection (5.35+2.50,4.79+2.28, 3.38+1.22, respectively) on through the end of the study
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Fig. 2 Kinetics of the Appearance of lgA:lgE Dual-Expressing B Cells, IgA Single-Expressing B 
Cells, and IgE Single-Expressing B Cells in the Small Intestine: Rats were infected with 2,000 
Trichinella spiralis muscle larvae on day 0. Samples of the small intestine 15cm from the pylorus were 
removed on the indicated days post infection and immunohistochemically processed to reveal IgA-lgE- 
Debc, IgA-Sebc, or IgE-Sebc in the small intestine. Data represent means ± standard deviation (SD) of 
6 rats per day per villus crypt unit (VCU).
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Fig. 3 Kinetics of the Appearance of IgMdgE Dual-Expressing B Cells, IgM Single-Expressing B
Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental procedures are
described in Fig. 2 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the small intestine. Data
represent means ± SD of 6 rats per day per VCU.
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Fig. 4 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental procedures are
described in Fig. 2 to reveal lgG1 :lgE-Debc, lgG1-Sebc, or IgE-Sebc in the small intestine. Data
represent means ± SD of 6 rats per day per VCU.
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Fig. 5 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental
procedures are described in Fig. 2 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the small
intestine. Data represent means ± SD of 6 rats per day per VCU.
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Fig. 6 Kinetics of the Appearance of lgG2b:lgE Dual-Expressing B Cells, lgG2b Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental
procedures are described in Fig. 2 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the small
intestine. Data represent means ± SD of 6 rats per day per VCU.
lgG2c:lgE Labeled B Cells in the Small Intestine
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Fig. 7 Kinetics of the Appearance of lgG2c:lgE Dual-Expressing B Cells, lgG2c Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental
Procedures are described in Fig. 2 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the small
intestine. Data represent means ± SD of 6 rats per day per VCU.
Numbers of Ab-Expressing B Cells in the Small Intestine
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DPI IgA only IgE only 1 IgA & IgE DPI IgM only IgE only | IgM & IgE
0 0.25 ±0.14 0.00 ± 0.00 0.30 ± 0.45 0 0.23 ±0.14 0.02 ± 0.03 0.08 ±0.11
1 0.13 + 0.14 0.10 ±0.02 0.46 ± 0.37 1 0.19 ±0.12 0.09 ± 0.22 0.56 ± 0.46
3 0.09 ± 0.06 0.02 ± 0.03 3.40 ± 1.1 5abc 3 0.18 ±0.06 0.06 ±0.10 3.83 ± 2.02ABC
5 0.03 ± 0.03 0.00 ± 0.00 7.58 ± 2.93ABC 5 0.04 ± 0.08 0.03 ± 0.04 6.18±2.76abc
7 0.74 ± 0.37 0.82 ± 0.94 28.13 ± 3.52abc 7 0.75 ± 0.06 0.53 ± 0.20 26.32 ± 8.20abg
10 0.39 ±0.16 0.32 ±0.19 21.26 ±4.71abc 10 0.51 ± 0.34 0.35 ±0.21 24.15 ±4.61abc
15 0.09 ± 0.09 0.09 ±0.10 13.73 + 5.32abc 15 0.08 ± 0.07 0.11 ±0.16 12.25 ± 2.84abc
DPI lgG1 only IgE only I lgG1 & IgE DPI lgG2a only IgE only | lgG2a & IgE
0 0.18±0.19 0.01 ± 0.02 0.21 ±0.18 0 0.00 ±0.00 0.00 ± 0.00 0.08 ± 0.09
1 0.10±0.10 0.00 ± 0.00 0.28 ± 0.37 1 0.08 ±0.13 0.00 ± 0.00 0.30 ± 0.37
3 0.23 ±0.11 0.05 ± 0.05 3.79±1.39ABC 3 0.06 ±0.06 0.01 ± 0.02 5.35 ± 2.50abc
5 0.03 ± 0.04 0.02 ±0.04 6.06±2.60abc 5 0.02 ± 0.03 0.00 ± 0.00 5.45±1.65abc
7 0.97 ± 0.78 0.84 ± 0.55 28.53 ± 3.26abc 7 0.60 ± 0.25 0.44 ±0.32 23.99 ± 5.75abc
10 0.64 ±0.31 0.39 ±0.12 29.01 ± 3.87abc 10 0.33 ±0.24 0.38 ± 0.25 24.76 ± 3.46abc
15 0.23 ±0.15 0.11 ±0.08 15.62 ± 2.98abc 15 0.11 ±0.07 0.20 ±0.10 13.87 ±3.38abc
DPI lgG2b only IgE only | lgG2b & IgE DPI lgG2c only IgE only | lgG2c & IgE
0 0.00 ± 0.00 0.00 ± 0.00 0.10±0.12 0 0.00 ± 0.00 0.00 ± 0.00 0.28 ± 0.26
1 0.03 ± 0.05 0.00 ± 0.00 0.12 ±0.29 1 0.06 ± 0.07 0.00 ± 0.00 0.42 ± 0.52
3 0.03 ± 0.06 0.01 ± 0.02 4.79 ± 2.28abc 3 0.08 ±0.12 0.05 ± 0.08 3.38 ± 1.22abc
5 0.01 ± 0.02 0.01 ± 0.02 2.57 ± 2.30abc 5 0.00 ± 0.00 0.01 ± 0.02 5.51 ±1.1 5abc
7 0.76 ±0.43 0.72 ±0.61 27.39 ± 3.06abc 7 0.61 ± 0.21 0.57 ± 0.35 25.23 ± 4.22abc
10 0.59 ± 0.36 0.44 ± 0.26 21.76 ±5.45abc 10 0.35 ± 0.23 0.33 ±0.19 22.79 ± 4.62abc
15 0.08 ±0.10 0.13±0.13 12.33 ±2.51abc 15 0.14 ±0.05 0.29 ±0.07 16.31 ± 3.05abc
Table 1 Summary of the means ± standard deviations per VCU of 6 rats of the kinetics of appearance of
dual Ab, and single Ab expression by B cells in the small intestine. A Indicates a significant increase in Ig-
Debc over the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @
p<0.05. c Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05.
Significance was determined according to Newman-Keuls Multiple-Range Test.
Table 2: Two-Factor ANOVA Comparisons in the Small Intestine
Two-Factor ANOVA: Comparison of the Different Dual Ab- 
Expressing B Cell Combinations in the Small Intestine
Source SS df MS 7= P-value F crit
Dual-Ab Effect 96.14 5 19.23 2.03 0.08 2.26
Day Effect 26175.3 6 4362.6 460.27 <0.0001 2.14
Interaction 419.84 30 13.99 1.48 0.06 1.51
Within 1990.44 210 9.48
Total 28681.8 251
Two-Factor ANOVA: Comparison Between lgA:lgE-Debc, 
IgA-Sebc, and IgE-Sebc in the Small Intestine
Source SS df MS F ' P-value Fcrit
Ab Effect 3076.00 2 1538.0 434.67 <0.0001 3.08
Day Effect 1525.65 6 254.27 71.86 <0.0001 2.19
Interaction 2682.45 12 223.54 63.18 <0.0001 1.85
Within 371.52 105 3.54
Total 7655.62 125
Two-Factor ANOVA: Comparison Between lgM:lgE-Debc, 
IgM-Sebc, and IgE-Sebc in the Small Intestine
Source SS df MS F P-value F crit
Ab Effect 2944.54 2 1472.3 284.20 <0.0001 3.08
Day Effect 1523.43 6 253.90 49.01 <0.0001 2.19
Interaction 2740.81 12 228.40 44.09 <0.0001 1.85
Within 543.94 105 5.18
Total 7752.71 125
Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc,
lgG1-Sebc, and IgE-Sebc in the Small Intestine
Source SS df MS F P-value Fcrit
Ab Effect 3803.45 2 1901.7 897.50 <0.0001 3.08
Day Effect 2084.16 6 347.36 163.93 <0.0001 2.19
interaction 3647.08 12 303.92 143.43 <0.0001 1.85
Within 222.49 105 2.12
Total 9757.17 125
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Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc,
lgG2a-Sebc, and IgE-Sebc in the Small Intestine
Source SS df MS F P-value F crit
Ab Effect 3010.92 2 1505.5 479.69 <0.0001 3.08
Day Effect 1423.32 6 237.22 75.59 <0.0001 2.19
Interaction 2546.74 12 212.23 67.62 <0.0001 1.85
Within 329.53 .105 3.14
Total 7310.51 125
Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc,
lgG2b-Sebc, and IgE-Sebc in the Small Intestine
Source SS df MS F P-value F crit
Ab Effect 2614.73 2 1307.4 483.15 <0.0001 3.08
Day Effect 1604.37 6 267.39 98.82 <0.0001 2.19
Interaction 2745.47 12 228.79 84.55 <0.0001 1.85
Within 284.12 105 2.71
Total 7248.69 125
Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc,
lgG2c-Sebc, and IgE-Sebc in the Small Intestine
Source SS df MS F P-value F crit
Ab Effect 3017.62 2 1508.8 611.93 <0.0001 3.08
Day Effect 1474.18 6 245.70 , 99.65 <0.0001 2.19
Interaction 2628.11 12 219.01 88.82 <0.0001 1.85
Within 258.89 105 2.47 •
Total 7378.80 125
Table 2. Two-factor ANOVA comparing the various Ab-expressing B cell 
combinations in the small intestine of rats. The comparisons resulting in 
significant F values were then subjected to a Student-Newman Keuls test to 
determine any significant differences between groups. The values of p<0.05 
were considered significant.
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controls (0.08±0.09, 0.10+0.12, and 0.28±0.26, respectively) (Fig. 5-7). IgG2a:IgE-Debc 
revealed the maximum on day 10 of infection (24.76±3.46) (Fig. 5), where as IgG2b:IgE- 
Debc (Fig. 6), and IgG2c:IgE-Debc (Fig. 7) showed a maximum proliferation on day 7 of 
infection (27.39±3.06 and 25.23±4.22). All of the dual Ab-combinations shown in this 
experiment had a significant decrease per villus on day 15 of infection as compared to the 
peak days of augmentation on day 7 and day 10, but the numbers of B cells were still 
significantly increased over the controls (Fig. 2-7). When comparing the respective IgE- 
Sebc, the IgA, IgM, IgGl, IgG2a, IgG2h, and IgG2c-Sebc, and the IgA, IgM, IgGl, 
IgG2a, IgG2b, and IgG2c-Debc, there were significant increases for all of the dual­
expressing B cells over the respective single-expressing B cells as of day 3 of infection, 
and such significance remained for the duration of the experiment (Fig. 2-7).
Significance for dual Ab-expressing B cells in the small intestine, as compared to the day 
0 controls, and between IgE-Sebc, the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Sebc, 
and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc was determined using a two- 
factor ANOVA. Differences resulting in significant F values were then subjected to a 
Student Newman-Keuls multiple-range test and are presented in Table 1 and Table 2.
3.2 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single Ab-
Expressing B Cells in the Spleen:
Spleen samples labeled with specific monoclonal mouse anti-rat IgA, IgM, IgGl, 
IgG2a, IgG2b, and IgG2c Ab respectively, and goat anti-rat IgE showed a significant 
increase in the number of double-labeled cells per field by day 5 of infection (Fig. 8-13).
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This significance was maintained for the remainder of the experiment as compared to the 
day 0 controls. There were no significant differences for different dual Ab-combinations 
between respective days of infection throughout the duration of the experiment. IgATgE 
Debc showed significant increase per field over the control (0.27±0.30) on day 5 of
infection (5.77±4.01) with a maximum value at day 10 (10.68±3.17) (Fig. 8). IgA-Sebc 
were very low per field in the spleen throughout the experiment with a maximum on day 
7 (0.28±0.12), and significantly less than the dual-expressing B cells as of day 1 of
infection (0.03±0.05 for Sebc; 0.64±0.14 for Debc). IgM:IgE-Debc showed similar
results to IgA:IgE-Debc with day 5 being significantly greater than day 0 (6.17+2.81;
0.53+0.33), and day 10 (10.51±3.41) being the maximum day of proliferation of dual-Ab 
expressing B cell (Fig. 9). IgGl :IgE-Debc showed the highest increase per field of dual­
expressing B cells on day 10 of infection (13.74+3.38), with the significant increase per
field over the control (0.58+0.21) as of day 5 (6.20+3.45) (Fig.10). IgG2a:IgE-Debc also
reached their highest proliferation on day 10 (11.21+2.02) with day 5 being the first day
of significant increase over the control (5.58+5.44 for day 5; 0.36+0.40 for day 0) (Fig.
11). IgG2b:IgE-Debc and IgG2c:IgE-Debc showed similar numbers of B cells detected 
per field and similar patterns of significant differences compared to the controls (Fig. 12 
and 13). B cells on Day 5 (5.38+3.72 for IgG2b:IgE-Debc; 5.63+4.46 for IgG2c:IgE-
Debc) showed significant increase over the controls (0.43+0.30 for IgG2b:IgE-Debc;
0.38+0.23 for IgG2c:IgE-Debc), and the peak day of proliferation of these cells was on
37
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Fig. 8 Kinetics of the Appearance of IgAJgE Dual-Expressing B Cells, IgA Single-Expressing B
Cells, and IgE Single-Expressing B Cells in the Spleen: Rats were infected with 2,000 Trichinella
spiralis muscle larvae on day 0. Samples of the spleen were removed on the indicated days post
infection and immunohistochemically processed to reveal lgA:lgE-Debc, IgA-Sebc, or IgE-Sebc in the
spleen. Data represent means ± standard deviation (SD) of 6 rats per day per field.
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Fig. 9 Kinetics of the Appearance of IgMdgE Dual-Expressing B Cells, IgM Single-Expressing B
Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental procedures are described in
Fig. 8 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the spleen. Data represent means + SD of 6
rats per day per field.
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Fig. 10 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental procedures
are described in Fig. 8 to reveal lgG1 :lgE-Debc, lgG1-Sebc, or IgE-Sebc in the spleen. Data represent
means ± SD of 6 rats per day per field.
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Fig. 11 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental procedures
are described in Fig. 8 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the spleen. Data
represent means ± SD of 6 rats per day per field.
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Fig. 12 Kinetics of the Appearance of lgG2b.TgE Dual-Expressing B Cells, lgG2b Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental procedures
are described in Fig. 8 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the spleen. Data
represent means ± SD of 6 rats per day per field.
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Fig. 13 Kinetics of the Appearance of lgG2c:lgE Dual-Expressing B Ceils, lgG2c Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental Procedures
are described in Fig. 8 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the spleen. Data
represent means + SD of 6 rats per day per field.
Number of Ab-Expressing B Cells in the Spleen
DPI IgA only IgE only IgA & IgE DPI IgM only IgE only IgM & IgE
0 0.10 + 0.10 0.02 ± 0.03 0.37 ± 0.30 0 0.39 ± 0.27 0.18 ±0.04 0.53 ± 0.33
1 0.03 ± 0.05 0.00 ± 0.00 0.72±O.14ab 1 0.48 ± 0.27 0.00 ±0.00 0.20 ±0.18
3 0.04 ± 0.08 0.06 ± 0.04 0.97 ± 0.08AB 3 0.23 ±0.12 0.04 ±0.04 0.10 ±0.06
5 0.09 ±0.16 0.11 ±0.16 5.77±4.01abc 5 0.10 ±0.12 0.27 ±0.26 6.17±2.81abc
7 0.28 + 0.12 0.22 ±0.14 4.77 ± 1.36ABC 7 0.36 ± 0.25 0.23 ±0.17 4.63 ± 1.38abc
10 0.08 ±0.10 0.08 ± 0.06 10.68 ± 3.1 7abc 10 0.08 ± 0.09 0.12 ±0.16 10.51 ±3.41abc
15 0.16 ±0.12 0.12±0.18 7.25 ± 2.20abc 15 0.12 ±0.10 0.14 ±0.09 7.05 ± 1.41abc
DPI lgG1 only IgE only lgG1 & IgE DPI IgG 2a only IgE only (gG2a & IgE
0 0.58 ± 0.56 0.12 ±0.03 0.58 ± 0.21 0 0.05 ± 0.08 0.02 ±0.03 0.36 ± 0.40
1 0.28 ±0.10 0.00 ± 0.00 0.75 ± 0.76 1 0.08 ±0.10 0.00 ± 0.00 0.08 ±0.12
3 0.16 ±0.06 0.03 ± 0.04 0.09 ± 0.04 3 0.07 ± 0.06 0.06 ± 0.06 0.09 ± 0.07
5 0.08 ±0.08 0.02 ± 0.03 6.20 ± 3.45ABC 5 0.33 ±0.65 0.04 ±0.05 5.58 ± 5.44ABC
7 0.29 ± 0.25 0.16±0.13 4.71 ± 1.38ABe 7 0.30 ±0.14 0.13 ±0.10 4.97 ± 1.34ABQ
10 0.12 ±0.11 0.07 ± 0.04 13.74 ± 3.38abc 10 0.12±0.11 0.09 ± 0.08 11.21 ±2.02abc
15 0.21 ±0.15 0.12 ± 0.11 7.88 ± 2.40ABC 15 0.11 ±0.23 0.18 ±0.16 9.35 ± 2.89abc
DPI lgG2b only IgE only lgG2b & IgE DPI lgG2c only IgE only lgG2c & IgE
0 0.10±0.10 0.01 ± 0.02 0.43 ± 0.30 0 0.03 ± 0.06 0.03 ± 0.03 0.38 ± 0.23
1 0.05 ± 0.08 0.01 ± 0.04 0.20 ±0.17 1 0.03 ± 0.05 0.00 ±0.00 0.07 ±0.08
3 0.07 ± 0.04 0.05 ±0.06 0.08 ±0.05 3 0.08 ±0.03 0.05 ±0.03 0.16 ±0.12
5 0.10 ±0.13 0.03 ± 0.04 5.38±3.72abc 5 0.13 ±0.09 0.09 ±0.10 5.63 ± 4.46ABC
7 0.23 ±0.18 0.15 ±0.10 5.16 ± 1.03ABC 7 ' 0.37 ± 0.22 0.22 ±0.13 5.19±0.54abc
10 0.08 ± 0.09 0.08 ± 0.08 12,17 ±3.36abc 10 0.11 ±0.09 0.18 ±0.10 11.93 ±1,54abc
15 0.16 ±0.19 0.05 ± 0.06 7.26 ± 1.93abc 15 0.17 ±0.15 0.06 ± 0.09 7.08 ± 2.77ABC
Table 3 Summary of the means + standard deviations per field of 6 rats of the kinetics of appearance of
dual Ab, and single Ab expression by B cells in the spleen. A Indicates a significant increase in Ig-Debc
over the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @ p<0.05. c
Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05. Significance was
determined according to Newman-Keuls Multiple-Range Test.
Table 4: Two-Factor ANOVA Comparisons in the Spleen
Two-Factor ANOVA: Comparison of the Different Dual Ab 
Expressing B Cell Combinations in the Spleen
Source SS df MS F P-value F crit
Dual-Ab Effect 13.04 5 2.61 0.57 0.72 2.26
Day Effect 4213.25 6 702.21 152.95 <0.0001 2.14
Interaction 61.17 30 2.04 0.44 1.00 1.51
Within 964.12 210 4.59
Total 5251.58 251
Two-Factor ANOVA: Comparison Between lgA:lgE-Debc, 
IgA-Sebc, and IgE-Sebc in the Spleen
Source SS df MS F P-value F crit
Ab Effect 469.96 2 234.98 147.13 <0.0001 3.08
Day Effect 200.77 6 33.46 20.95 <0.0001 2.19
Interaction 399.75 12 33.31 20.86 <0.0001 1.85
Within 167.70 105 1.60
Total 1238.19 125
Two-Factor ANOVA: Comparison Between lgM:lgE-Debc, 
IgM-Sebc, and IgE-Sebc in the Spleen
Source SS df MS F P-value F crit
Ab Effect 465.10 2 232.55 206.21 <0.0001 3.08
Day Effect 197.57 6 32.93 29.20 <0.0001 2.19
Interaction 387.63 12 32.30 28.64 <0.0001 1.85
Within 118.41 105 1.13
Total 1168.72 125
Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc, 
lgG1-Sebc, and IgE-Sebc in the Spleen
Source SS df MS F P-value F crit
Ab Effect 624.02 2 312.01 203.63 <0.0001 3.08
Day Effect 293.17 6 48.86 31.89 <0.0001 2.19
Interaction 594.54 12 49.54 32.33 <0.0001 1.85
Within 160.88 105 1.53
Total 1672.62 125
45
Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc,
lgG2a-Sebc, and IgE-Sebc in the Spleen
Source SS df MS F P-value F crit
Ab Effect 526.08 2 263.04 123.30 <0.0001 3.08
Day Effect 257.66 6 42.94 20.13 <0.0001 2.19
Interaction 499.13 12 41.59 19.50 <0.0001 1.85
Within 224.00 105 2.13
Total 1506.88 125
Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc,
lgG2b-Sebc, and IgE-Sebc in the Spleen
Source SS df MS F P-value F crit
Ab Effect 506.90 2 253.45 176.16 <0.0001 3.08
Day Effect 252.65 6 42.11 29.27 <0.0001 2.19
Interaction 480.69 12 40.06 27.84 <0.0001 1.85
Within 151.07 105 1.44
Total 1391.31 125
Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc,
lgG2c-Sebc, and IgE-Sebc in the Spleen
Source SS df MS F ' P-value Fcrit
Ab Effect 506.95 2 253.48 174.59 <0.0001 3.08
Day Effect 239.84 6 39.97 27.53 <0.0001 2.19
Interaction 474.94 12 39.58 27.26 <0.0001 1.85
Within 152.45 105 1.45
Total 1374.18 125
Table 4. Two-factor ANOVA comparing the various Ab-expressing B cell 
combinations in the spleen of rats. The comparisons resulting in significant F 
values were then subjected to a Student-Newman Keuls test to determine 
any significant differences between groups. The values of p<0.05 were 
considered significant.
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day 10 (12.17+3.36 for IgG2b:IgE-Debc; 11.93±1.54 for IgG2c:IgE-Debc) for each 
combination. All of the dual Ab-combinations except for IgG2a:IgE-Debc showed a 
significant decrease on day 15 of infection as compared to the peak days of infection on 
day 10 (Fig. 8-13). When comparing the respective IgE-Sebc, the IgA, IgM, IgGl,
IgG2a, IgG2b, and IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc, 
there were significant increases for the dual-expressing B cells over the respective single­
expressing B cells, except IgA:IgE-Debc to IgA-Sebc and IgE-Sebc, as of day 5 of 
infection, and such significance remained for the duration of the experiment (Fig. 8-13). 
Significance for dual Ab-expressing B cells in the spleen, as compared to the day 0 
controls, and between IgE-Sebc, the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Sebc, and 
the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc was determined using a two-factor 
ANOVA. Differences resulting in significant F values were then subjected to a Student 
Newman-Keuls multiple-range test and are presented in Table 3 and Table 4.
3.3 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single Ab-
Expressing B Cells in the Mesenteric Lymph Node:
Mesenteric Lymph Node (MLN) samples labeled with specific monoclonal mouse
anti-rat IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c Ab respectively, and goat anti-rat IgE 
showed a significant increase in the number of double-labeled B cells per field by day 7 
of infection (Fig. 14-19). This significance was maintained for the remainder of the 
experiment as compared to the day 0 controls. There were no significant differences for 
different dual Ab-combinations between respective days throughout the duration of the
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experiment. IgA:IgE-Debc showed significant increase per field over the control 
(0.95±0.52) on day 7 of infection (4.91 ±1.50) with a maximum reached on day 10
(13.23+3.52) (Fig. 14). IgM:IgE-Debc showed similar results to IgA.TgE-Debc with day
7 being significantly greater than day 0 (3.31+2.64; 0.39+0.56), and day 10 (13.18+6.34) 
being the maximum day of augmentation of dual-Ab expressing B cells (Fig. 15).
IgGl :IgE-Debc showed a significant increase of dual-expressing B cells on day 7 of 
infection (4.39+1.35), but the peak day of dual Ab expression happened on day 15
(9.35+2.40) rather than day 10 like the other dual-Ab combinations in this tissue (Fig. 
16). IgG2a:IgE-Debc and IgG2b:IgE-Debc showed similar dynamics of activation to the 
IgA:IgE-Debc and IgM:IgE-Debc with day 7 (3.43+2.28 for IgG2a:IgE-Debc and
3.66+1.53 for IgG2b:IgE-Debc) demonstrating significant proliferation of B cells, and
day 10 (8.48+4.01 for IgG2a:IgE-Debc and 10.25+3.58 for IgG2b:IgE-Debc) being the 
peak day of proliferation (Fig. 17-18) . Similar results were obtained in the number of 
IgG2c:IgE-Debc to that of the IgGl :IgE-Debc, but the values showed less overall
activation. Day 7 (3.32+1.76) was the first day of significant increase over the control
(1.11+0.39), and day 15 (7.25+2.77) was the peak day of activation (Fig. 19). ). When 
comparing the respective IgE-Sebc, the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Sebc, 
and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc, there were significant increases 
for all of the dual-expressing B cells over the respective single-expressing B cells, except 
IgA:IgE-Debe to IgA-Sebc, as of day 3 of infection, and such significance remained for
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Fig. 14 Kinetics of the Appearance of lgA:lgE Dual-Expressing B Cells, IgA Single-Expressing 
B Cells, and IgE Single-Expressing B Cells in the Mesenteric Lymph Node (MLN): Rats were 
infected with 2,000 Trichinella spiralis muscle larvae on day 0. Samples of the MLN were removed on 
the indicated days post infection and immunohistochemically processed to reveal lgA:lgE-Debc, IgA- 
Sebc, or IgE-Sebc in the MLN. Data represent means + standard deviation (SD) of 6 rats per day per 
field.
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Fig. 15 Kinetics of the Appearance of IgMJgE Dual-Expressing B Cells, IgM Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the MLN: Experimental procedures are described in
Fig. 14 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the MLN. Data represent means ± SD of 6
rats per day per field.
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Fig. 16 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the MLN: Experimental procedures are
described in Fig. 14 to reveal lgG1 :lgE-Debc, lgG1-Sebc, or IgE-Sebc in the MLN. Data represent
means + SD of 6 rats per day per field.
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Fig. 17 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a Single-
Expressing B Cells, and IgE Single-Expressing B Ceils in the MLN: Experimental procedures are
described in Fig. 14 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the MLN. Data represent
means ± SD of 6 rats per day per field.
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Fig. 18 Kinetics of the Appearance of lgG2b:lgE Dual-Expressing B Cells, lgG2b Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the MLN: Experimental procedures are
described in Fig. 14 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the MLN. Data represent
means + SD of 6 rats per day per field.
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Fig. 19 Kinetics of the Appearance of igG2c:lgE Dual-Expressing B Cells, lgG2c Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the MLN: Experimental Procedures are
described in Fig. 14 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the MLN. Data represent
means + SD of 6 rats per day per field.
Numbers of Ab-Expressing B Cells in the Mesenteric Lymph Node
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DPI IgA only IgE only I IgA & IgE DPI IgM only IgE only IgM & IgE
0 1.48 ±0.14 0.20 ±0.02 0.95 ± 0.74 0 0.18 ±0.21 0.03 ± 0.00 0.39 ± 0.56
1 0.25 ±0.16 0.02 ± 0.06 0.14 ±0.04 1 0.23 ± 0.22 0.05 ± 0.04 0.31 ± 0.08
3 1.37 ±0.10 0.10 ±0.02 2.61±1.00B 3 0.39 ± 0.20 0.03 ± 0.22 2.35±1.72AB
5 0.98 ± 0.36 0.28 ±0.19 1.77±0.42b 5 0.08 ±0.16 0.00 ± 0.00 1.56±0.80ab
7 0.01 ± 0,00 0.01 ± 0.00 4.91±1.50abc 7 0.00 ± 0.02 0.00 ± 0.02 3.31 ± 2.64ABC
10 0.06 ± 0.02 0.04 ± 0.06 13.23 ±3.52abc 10 0.00 ± 0.05 0.04 ± 0.05 13,18 ±6.34abc
15 0.12 ±0.12 0.14 ±0.18 7.05 ± 2.20abc 15 0.21 ±0.10 0.12 ±0.09 7.88 ± 1.41ABC
DPI lgG1 only IgE only lgG1 & IgE DPI lgG2a only IgE only lgG2a & IgE
0 0.33 + 0.08 0.23 ± 0.04 0.73 ± 0.53 0 0.05 ± 0.03 0.00 ± 0.06 0.39 ± 0.27
1 0.13 ±0.03 0.19 ±0.07 0.64 ± 0.42 1 0.03 ±0.14 0.03 ± 0.05 0.05 ± 0.66
3 0.19 ±0.45 0.03 ±0.04 2.01±1.75ab 3 0.23 ± 0.22 0.07 ±0.06 1.37±1.54AB
5 0.00 ± 0.20 0.01 ± 0.00 1.21 ± 0.57ab 5 0.01 ± 0.00 0.02 ± 0.02 1.40±0.57ab
7 0.00 ± 0.00 0.00 ± 0.00 4.39±1.35abc 7 0.00 ±0.00 0.00 ± 0.00 3.43 ± 2.28ABC
10 0.03 + 0.00 0.13 ±0.07 8.16±1.64abc 10 0.04 ± 0.06 0.03 ±0.24 8.48 ± 4.01ABC
15 0.20 ±0.15 0.18±0.11 9.35 ± 2.40ABC 15 0.16 ±0.23 0.05 ±0.16 7.26 ± 2.89ABC
DPI lgG2b only IgE only lgG2b & IgE DPI lgG2c only IgE only lgG2c & IgE
0 0.11 ±0.08 0.08 ± 0.00 0.58 ± 0.24 0 0.61 ± 0.02 0.00 ±0.03 0.11 ±0.39
1 0.05 ± 0.08 0.00 ± 0.04 0.27 ± 0.27 1 0.28 ±0.12 0.04 ±0.00 0.02 ± 0.29
3 0.46 ±0.17 0.01 ±0.10 1.78±1.22AB 3 0.23 ± 0.62 0.18 ±0.02 1.48±0.54AB
5 0.00 ± 0.02 0.02 ± 0.03 1.04±0.92ab 5 0.02 ± 0.00 0.00 ± 0.05 1.14±0.35ab
7 0.00 ± 0.00 0.00 ±0.00 3.66±1.53abc 7 0.00 ± 0.00 0.00 ± 0.00 3.32±1.76abc
10 0.07 ± 0.06 0.02 ± 0.06 10.25 ±3.58abc 10 0.01 ± 0.08 0.05 ± 0.03 6.99 ± 4.73ABC
15 0.17 ±0.19 0.06 ±0.06 7.08±1.93abc 15 0.16 ±0.15 0.12 ±0.09 7.25±2.77abc
Table 5 Summary of the means + standard deviations per filed of 6 rats of the kinetics of appearance of 
dual Ab, and single Ab expression by B cells in the MLN. A Indicates a significant increase in Ig-Debc over
the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @ p<0.05. c 
Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05. Significance was 
determined according to Newman-Keuls Multiple-Range Test.
Table 6: Two-Factor ANOVA Comparisons in the Mesenteric Lymph 
Node
Two-Factor ANOVA: Comparison of the Different Dual Ab- 
Expressing B Cell Combinations in the MLN
Source SS df MS F P-value F crit
Dual-Ab Effect 57.85 5 11.57 2.76 0.02 2.26
Day Effect 3081.25 6 513.54 122.53 <0.0001 2.14
Interaction 204.78 30 6.83 1.63 0.03 1.51
Within 880.16 210 4.19
Total 4224.03 251
Two-Factor ANOVA: Comparison Between IgAJgE-Debc, 
IgA-Sebc, and IgE-Sebc in the MLN
Source SS df MS F P-value Fcrit
Ab Effect 248.37 2 124.19 123.56 <0.0001 3.08
Day Effect 101.10 6 16.85 16.76 <0.0001 2.19
Interaction 213.07 12 17.76 17.67 <0.0001 1.85
Within 105.53 105 1.01
Total 668.08 125
Two-Factor ANOVA: Comparison Between lgM:lgE-Debc, 
IgM-Sebc, and IgE-Sebc in the MLN
Source SS df MS F P-value F crit
Ab Effect 517.35 2 258.68 101.45 <0.0001 3.08
. Day Effect 249.74 6 41.62 16.32 <0.0001 2.19
Interaction 504.17 12 42.01 16.48 <0.0001 1.85
Within 267.73 105 2.55
Total 1538.99 125
Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc,
lgG1-Sebc, and IgE-Sebc in the MLN
Source SS df MS F P-value F crit
Ab Effect 457.67 2 228.84 330.68 <0.0001 3.08
Day Effect 270.69 6 45.12 65.19 <0.0001 2.19
Interaction 540.47 12 45.04 65.08 <0.0001 1.85
Within 72.66 105 0.69
Total 1341.50 125
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Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc,
lgG2a-Sebc, and IgE-Sebc in the MLN
Source SS df MS F P-value F crit
Ab Effect 378.89 2 189.44 120.10 <0.0001 3.08
Day Effect 155.51 6 25.92 16.43 <0.0001 2.19
Interaction 322.83 12 26.90 17.06 <0.0001 1.85
Within 165.62 105 1.58
Total 1022.85 125
Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc,
lgG2b-Sebc, and IgE-Sebc in the MLN
Source SS df MS F P-value F crit
Ab Effect 268.28 2 134.14 130.23 <0.0001 3.08
Day Effect 139.18 6 23.20 22.52 <0.0001 2.19
Interaction 274.64 12 22.89 22.22 <0.0001 1.85
Within 108.15 105 1.03
Total 790.27 125
Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc,
lgG2c-Sebc, and IgE-Sebc in the MLN
Source SS df MS F P-value F crit
Ab Effect 335.41 2 167.71 103.85 <0.0001 3.08
Day Effect 171.78 6 28.63 17.73 <0.0001 2.19
Interaction 347.29 12 28.94 17.92 <0.0001 1.85
Within 169.56 105 1.61
Total 1024.05 125
Table 6. Two-factor ANOVA comparing the various Ab-expressing B cell 
combinations in the MLN of rats. The comparisons resulting in significant F 
values were then subjected to a Student-Newm'an Keuls test to determine
any significant differences between groups. The values of p<0.05 were 
considered significant.
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the duration of the experiment (Fig. 14-19). IgA:IgE-Debc were significantly increased 
over the IgA-Sebc on day 7 of infection (0.01+0.00 for IgA-Sebc and 4.91+1.50 for 
IgA:IgE-Debc). Significance for dual Ab-expressing B cells in the MLN, as compared to 
the day 0 controls, and between IgE-Sebc, the IgA, IgM, IgGl, IgG2a, IgG2b, and 
IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc was determined 
using a two-factor ANOVA. Differences resulting in significant F values were then 
subjected to a Student Newman-Keuls multiple-range test and are presented in Table 5
and Table 6.
3.4 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single Ab-
Expressing B Cells in the Non-Germinal Center Region of the Peyer’s Patches:
Samples of the non-germinal center regions of the Peyer’s patches (PP-NGC) 
labeled with specific monoclonal mouse anti-rat IgA, IgM, IgGl, IgG2a, IgG2b, and 
IgG2c Ab respectively, and goat anti-rat IgE showed a significant increase in the number 
of double labeled cells per field by day 7 of infection (Fig. 20-25). This significance was 
maintained for the remainder of the experiment as compared to the day 0 controls. There 
were no significant differences for different dual Ab-combinations between respective 
days throughout the duration of the experiment. IgA:IgE-Debc showed significant 
increase over the control (0.11+0.08) on day 7 of infection (2.37+1.18) with a maximum 
value at day 10 (3.65+1.00) (Fig. 20). Similar kinetics of proliferation were obtained in
IgM:IgE-Debc with day 7 being significantly greater than day 0 (2.56+1.06; 0.04+0.18),
and day 10 (2.86+2.67) being the maximum proliferation of dual-Ab expressing B cell
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(Fig. 21). IgGl TgE-Debc showed a significant increase on day 7 of infection 
(2.78+2.17) when compared to the control (0.07+0.08), and this was also the peak day of 
proliferation (Fig. 22). IgG2a:IgE-Debc showed maximum augmentation on day 7
(2.07+2.05) which was the first day of significant increase over the control (0.09+0.06).
Similar numbers of B cells were also found on day 15 (2.50+1.08) (Fig. 23). IgG2b:IgE- 
Debc like IgGl TgE-Debc had the highest increase in dual-expressing B cells on day 7 
(3.76+1.22) of infection, and this was also the first day of significant increase per field
over the control (0.03+0.13) (Fig. 24). The final combination, IgG2c:IgE-Debc, was
increased significantly on day 7 (2.29+2.76), and this was also the peak day of 
proliferation (Fig. 25). When comparing the respective IgE-Sebc, the IgA, IgM, IgGl, 
IgG2a, IgG2b, and IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc, 
there were significant increases for all of the dual-expressing B cells over the respective 
single-expressing B cells as of day 7 of infection, and such significant increases remained 
for the duration of the experiment. Significance for dual Ab-expressing B cells in the PP- 
NGC, as compared to the day 0 controls, and between IgE-Sebc, the IgA, IgM, IgGl, 
IgG2a, IgG2b, and IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2h, and IgG2c-Debc 
was determined using a two-factor ANOVA. Differences resulting in significant F values 
were then subjected to a Student Newman-Keuls multiple-range test and are presented in
Table 7 and Table 8.
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Fig. 20 Kinetics of the Appearance of IgA'.IgE Dual-Expressing B Cells, IgA Single-Expressing 
B Ceils, and IgE Single-Expressing B Cells in the Non-Germinal Center Region of the Peyer's 
Patch (PP-NGC): Rats were infected with 2,000 Trichinella spiralis muscle larvae on day 0. Samples 
of the PP-ngc were removed on the indicated days post infection and immunohistochemically 
processed to reveal lgA:igE-Debc, IgA-Sebc, or IgE-Sebc in the PP-NGC. Data represent means +_ 
standard deviation (SD) of 6 rats per day per field.
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Fig. 21 Kinetics of the Appearance of lgM:lgE Dual-Expressing B Cells, IgM Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental procedures are
described in Fig. 20 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the PP-NGC. Data represent
means + SD of 6 rats per day per field.
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Fig. 22 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental procedures
are described in Fig. 20 to reveal lgG1:lgE-Debc, lgG1-Sebc, or IgE-Sebc in the PP-NGC. Data
represent means ± SD of 6 rats per day per field.
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Fig. 23 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental procedures
are described in Fig. 20 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the PP-NGC. Data
represent means ± SD of 6 rats per day per field.
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Fig. 24 Kinetics of the Appearance of lgG2b:lgE Dual-Expressing B Cells, lgG2b Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental procedures
are described in Fig. 20 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the PP-NGC. Data
represent means ± SD of 6 rats per day per field.
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Fig. 25 Kinetics of the Appearance of lgG2c:lgE Dual-Expressing B Cells, lgG2c Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental Procedures
are described in Fig. 20 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the PP-NGC. Data
represent means ± SD of 6 rats per day per field.
Numbers of Ab-Expressing B Cells in the Peyer's Patch - Non Germinal Centers
Ol
G)
DPI IgA only IgE only I IgA & IgE DPI IgM only IgE only IgM & IgE
0 0.18 ±0.09 0.00 ± 0.00 0.11 ±0.08 0 0.03 ±0.14 0.01 ±0.00 0.04 ±0.18
1 0.14 ±0.04 0.00 ± 0.00 0.42 ± 0.22 1 0.00 ±0.10 0.00 ± 0.00 0.37 ± 0.35
3 0.33 ± 0.32 0.41 ± 0.02 0.90 ±0.66 3 0.25 ±0.16 0.12 ±0.02 0.69 ± 0.43
5 0.08 ± 0.67 0.22 ±0.12 0.18 ±1.88 5 0.07 ± 0.08 0.02 ± 0.25 0.08 ±0.18
7 0.01 ± 0.04 0.00 ± 0.03 2.37 ±1.18ABC 7 0.01 ± 0.02 0.02 ± 0.00 2.56±1.06ABC
10 0.01 + 0.06 0.01 ±0.10 3.65 ± 1.00ABC 10 0.02 ± 0.02 0.04 ± 0.02 2.86 ± 2.67abc
15 0.02 ± 0.08 0.04 ±0.06 2.59±1.59abc 15 0.05 ± 0.03 0.08 ±0.05 2.43 ± 1.62abc
DPI lgG1 only IgE only lgG1 & IgE DPI lgG2a only IgE only lgG2a & IgE
0 0.01 ± 0.04 0.00 ± 0.02 0.07 ± 0.08 0 0.05 ± 0.02 0.00 ± 0.00 0.09 ± 0.06
1 0.01 ± 0.00 0.01 ± 0.00 0.32 ± 0.30 1 0.02 ± 0.02 0.01 ± 0.02 0.16 ±0.32
3 0.03 ±0.11 0.02 ± 0.04 1.40 ±0.25 3 0.06 ±0.14 0.02 ± 0.04 1.00 ±0.91
5 0.17 ±0.07 0.14 ±0.03 0.40 ± 0.00 5 0.29 ± 0.22 0.17 ±0.09 0.32 ± 0.38
7 0.02 ± 0.02 0.00 ± 0.04 2.78±2.17abc 7 0.00 ± 0.03 0.05 ±0.00 2.07 ± 2.05abc
10 0.08 ± 0.03 0.05 ± 0.05 2.53±2.38abc 10 0.04 ±0.10 0.03 ± 0.04 2.39 ± 1.44ABG
15 0.05 ± 0.06 0.04 ±0.06 1.99 ± 1.24abc 15 0.05 ± 0.04 0.04 ± 0.05 2.50 ± 1.08ABC
DPI lgG2b only IgE only lgG2b & IgE DPI lgG2c only IgE only lgG2c & IgE
0 0.01 ± 0.06 0.01 ± 0.00 0.03 ±0.13 0 0.15 ±0.02 0.00 ± 0.02 0.05 ±0.06
1 0.14 ±0.03 0.12 ±0.02 0.48 ±0.14 1 0.14 ±0.09 0.10 ±0.03 0.40 ± 0.24
3 0.01 ± 0.08 0.02 ± 0.04 0.93 ± 0.43 3 0.53 ± 0.02 0.21 ± 0.05 0.71 ±0.76
5 0.23 ± 0.09 0.18±0.17 0.74 ± 0.23 5 0.38 ± 0.22 0.25 ±0.17 0.75 ±1.20
7 0.04 ±0.00 0.03 ± 0.06 3.76 ± 1.22abc 7 0.03 ± 0.05 0.00 ± 0.04 2.29 ± 2.76abc
10 0.06 ± 0.05 0.07 ± 0.04 2.34±1.38abc 10 0.03 ± 0.07 0.05 ± 0.06 1.86±1.46abc
15 0.02 ± 0.04 0.00 ± 0.03 1.90 ± 1.31abc 15 0.04 ± 0.03 0.07 ± 0.00 2.09 ± 1.08abc
Table 7 Summary of the means + standard deviations per field of 6 ratsof the kinetics of appearance of
dual Ab, and single Ab expression by B cells in the PP-NGC. A Indicates a significant increase in Ig-Debc
over the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @ p<0.05. c
Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05. Significance was
determined according to Newman-Keuls Multiple-Range Test.
Table 8:Two-Factor ANOVA Comparisons in the Non-Germinal Center 
Regions of the Peyer's Patch
Two-Factor ANOVA: Comparison of the Different Dual Ab- 
Expressing B Cell Combinations in the PP-NGC
Source SS df MS F P-value F crit
Dual-Ab Effect 2.53 5 0.51 0.36 0.88 2.26
Day Effect 282.62 6 47.10 33.51 <0.0001 2.14
Interaction 30.63, 30 1.02 0.73 0.85 1.51
Within 295.23 210 1.41
Total 611.00 251
Two-Factor ANOVA:.Comparison Between lgA:lgE-Debc, 
IgA-Sebc, and IgE-Sebc,in the PP-NGC
Source SS df MS F P-value F crit
Ab Effect 56.03 .2 28.02 , 64.11 <0.0001 .3.08
Day Effect 13.11 6 2.18 5.00 <0.0001 2J9
Interaction 25.47 12 2.12 4.86 <0.0001 1.85
Within 45.88 105 0.44
Total 140.49 125
Two-Factor ANOVA: Comparison Between lgM:lgE-Debc, 
IgM-Sebc, and IgE-Sebc in the PP-NGC
Source SS df MS F P-value F crit
Ab Effect 56.52 2 28.26 52.40 <0.0001 3.08
Day Effect 23.44 6 3.91. 7.24 <0.0001 2.19
Interaction 47.26 12 3.94 7.30 <0.0001 1.85
Within 56.62 105 0.54
Total 183.85 125
Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc, 
lgG1-Sebc, and IgE-Sebc in the PP-NGC
Source SS df MS F P-value F crit
Ab Effect 41.09 2 20.55 33.91 <0.0001 3.08
Day Effect 17.64 6 2.94 4.85 <0.0001 2.19
Interaction 40.47 12 3.37 5.57 <0.0001 1.85
Within 63.62 105 0.61
Total 162.82 125
67
Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc, 
lgG2a-Sebc, and IgE-Sebc in the PP-NGC
Source SS df MS F P-value F crit
Ab Effect 47.04 2 23.52 57.46 <0.0001 3.08
Day Effect 14.19 6 2.37 5.78 <0.0001 2.19
Interaction 30.79 12 2.57 6.27 <0.0001 1.85
Within 42.98 105 0.41
Total 135.01 125
Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc, 
lgG2b-Sebc, and IgE-Sebc in the PP-NGC
Source SS df MS F P-value Fcrit
Ab Effect 36.99 2 18.49 70.47 <0.0001 3.08
Day Effect 12.16 6 2.03 7.72 <0.0001 2.19
Interaction 30.37 12 2.53 9.64 <0.0001 1.85
Within 27.55 105 0.26
Total 107.07 125
Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc, 
lgG2c-Sebc, and IgE-Sebc in the PP-NGC
Source SS df MS F P-value Fcrit
Ab Effect 55.25 2 27.62 44.42 <0.0001 3.08
Day Effect 19.94 6 3.32 5.34 <0.0001 2.19
Interaction 40.81 12 3.40 5.47 <0.0001 1.85
Within 65.30 105 0.62
Total 181.29 125
Table 8. Two-factor ANOVA comparing the various Ab-expressing B cell 
combinations in the PP-NGC of rats. The comparisons resulting in significant 
F values were then subjected to a Student-Newman Keuls test to determine
any significant differences between groups. The values of p<0.05 were 
considered significant.
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3.5 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single Ab-
Expressing B Cells in the Germinal Center Region of the Peyer’s Patches:
Samples of the germinal center regions of the Peyer’s patches (PP-GC) were
labeled with specific monoclonal mouse anti-rat IA, IgM, IgGl, IgG2a, IgG2b, and 
IgG2c, and goat anti-rat IgE. The results showed that the number of IgA:IgE-Debc were 
significantly increased as compared to the controls (2.65±2.85) as of day 5 of infection
(9.78±4.78), and it remained significantly increased for the remainder of the experiment
(Fig. 26). Significant increase was also shown on day 10 (23.16±7.46) and day 15
(24.32±1.75) over the day 5 infected rats, and these were the peak days of B cell
proliferation. IgM:IgE-Debc showed a sharp significant increase as of day 1 of infection
(8.03±2.62 ). This was followed by a decrease on day 3 (3.97±3.85) that was not
significantly increased over the controls (Fig. 27). On day 7(11.22+1.28) the dual­
expressing B cells were again significantly increased over the control, and remained 
increased for the remainder of the experiment. IgGl :IgE-Debc and IgG2a:IgE-Debc 
showed similar results in B cell proliferation, with a significant increase per field over the 
controls (1,98±2.15 for IgGl:IgE-Debc; 2.71±3.11 for IgG2a:IgE-Debc) as of day 7
(10.04±1.23 for IgGl:IgE-Debc; 7.98±1.49 for IgG2a:IgE-Debc) of infection and such 
kinetics remained throughout the duration of the experiment (Fig. 28 and 29, 
respectively). IgG2b:IgE-Debc and IgG2c:IgE-Debc showed similar ranges of B cells 
proliferation to that of the IgM:IgE-Debc. These two combinations showed sharp 
significant increase as of day 1 of infection (6.50±2.25 for IgG2b:IgE-Debc; 5.84±1.75 
for IgG2c:IgE-Debc), followed by a decrease on day 3 (3.97±2.03 for IgG2b:IgE-Debc;
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5.08±l .39 for IgG2c:IgE-Debc) of infection that was not significantly increased over the
respective controls (Fig. 30 and 31, respectively). On day 7 (8.14±1.03 for IgG2b:IgE-
Debc; 9.37±1.25 for IgG2c:IgE-Debc) the dual-expressing B cells were again 
significantly increased over the control, and remained increased for the remainder of the 
experiment. IgA-Sebc and IgM-Sebc were significantly higher than the other single Ab- 
expressing B cells on day 1 and day 3 of infection, but became similar, with no 
significant differences, to the other single Ab-expressing B cells as the days of infection 
proceeded. As compared to the IgA:IgE-Debc, the number of IgA-Sebc was significantly 
less per field than the dual-expressing B cells as of day 3 (1.05±0.56 for IgA-Sebc;
6.28+2.46 for IgA:IgE-Debc) of infection (Fig. 26). The kinetics of the numbers of IgM- 
Sebc were similar to that of IgA-Sebc, with day 3 being the first day significantly 
declined compared to the IgM:IgE-Debc (0.56±0.70 for IgM-Sebc; 3.97±3.85 for
IgM:IgE-Debc) (Fig. 27). The numbers of IgGl-Sebc, IgG2a-Sebc, IgG2b-Sebc, and 
IgG2c-Sebc were all significantly less than that of the respective dual-expressing B cells 
for the entire experiment (Fig. 28, 29, 30, and 31 respectively). IgE-Sebc for each group 
of rats was also significantly less in number than that of the respective dual-expressing B 
cells for the entire experiment. Significance for dual Ab-expressing B cells in the PP- 
GC, as compared to the day 0 controls, and between IgE-Sebc, the IgA, IgM, IgGl, 
IgG2a, IgG2b, and IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc 
was determined using a two-factor ANOVA. Differences resulting in significant F values 
were then subjected to a Student Newman-Keuls multiple-range test and are presented in
Table 9 and Table 10.
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Fig. 26 Kinetics of the Appearance of lgA:lgE Dual-Expressing B Cells, IgA Single-Expressing 
B Cells, and IgE Single-Expressing B Cells in the Germinal Center Region fo the Peyer's Patch 
(PP-GC): Rats were infected with 2,000 Trichinella spiralis muscle larvae on day 0. Samples of the 
. PP-GC were removed on the indicated days post infection and immunohistochemicaily processed to 
reveal lgA:lgE-Debc, IgA-Sebc, or IgE-Sebc in the PP-GC. Data represent means ± standard deviation
(SD) of 6 rats per day per field.
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Fig. 27 Kinetics of the Appearance of lgM:lgE Dual-Expressing B Cells, IgM Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental procedures are described
in Fig. 26 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the PP-GC. Data represent means ± SD
of 6 rats per day per field.
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Fig. 28 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental procedures
are described in Fig. 26 to reveal lgG1 :lgE-Debc, lgG1-Sebc, or IgE-Sebc in the PP-GC. Data
represent means ± SD of 6 rats per day per field.
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Fig. 29 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental procedures
are described in Fig. 26 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the PP-GC. Data
represent means + SD of 6 rats per day per field.
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Fig. 30 Kinetics of the Appearance of lgG2b:lgE Dual-Expressing B Cells, lgG2b Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental procedures
are described in Fig. 26 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the PP-GC. Data
represent means + SD of 6 rats per day per field.
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Fig. 31 Kinetics of the Appearance of lgG2c:lgE Dual-Expressing B Cells, lgG2c Single-
Expressing B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental Procedures
are described in Fig. 26 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the PP-GC. Data
represent means ± SD of 6 rats per day per field.
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Numbers of Ab-Expressing B Cells in the Peyer’s Patch - Germinal Centers
DPI IgA only IgE only IgA & IgE DPI IgM only IgE only IgM & IgE
0 2.59 ±1.87 0.09 ±0.13 2.65 ± 2.85B 0 1.27 ±0.42 0.02 ± 0.05 2.88 ± 1,99B
1 2.97 ±1.73 0.14 ±0.17 6.64 ± 2.24b 1 3.94 ± 3.63 0.04 ± 0.10 8.03 ± 2.62abc
3 1.05 ±0.56 0.20 ± 0.32 6.28 ± 2.46ab 3 0.56 ± 0.70 0.29 ± 0.51 3.97 ± 3.85ab
5 0.83 ± 2.04 0.00 ± 0.00 9.78 ± 4.78abc 5 0.25 ±0.61 0.25 ±0.42 5.58 ± 2.06ab
7 0.08 ±0.11 0.02 ± 0.05 9.30 ± 3 09abc 7 0.09 ±0.12 0.07 ±0.12 11.22 ± 1.28abc
10 0.31 ± 0.48 0.18 ±0.27 23.16 ±7.46abc 10 0.12 ±0.15 0.21 ± 0.28 17.85 ± 2.46ABC
15 0.40 ± 0.29 0.27 ±0.19 24.32 ±1.75abc 15 0.41 ± 0.65 0.48 ± 0.44 30.45 ± 16.83abc
DPI lgG1 only IgE only lgG1 & IgE DPI lgG2a only IgE only lgG2a & IgE
0 0.39 ± 0.56 0.00 ± 0.00 1.98±2.15ab 0 0.27 ± 0.42 0.03 ± 0.07 2.71±3.11AB
1 0.49 ±0.42 0.40 ± 0.37 6.35 ± 2.77ab 1 0.09 ±0.15 0.17 ±0.28 5.83 ± 3.52ab
3 0.44 ± 0.39 0.33 ±0.58 4.78 ± 3.30ab 3 0.32 ± 0.26 0.21 ±0.17 6.49 ± 4.64AB
5 0.33 ± 0.52 0.25 ± 0.27 3.17±1.97ab 5 0.00 ±0.00 0.00 ± 0.00 3.33±5.43ab
7 0.08 ± 0.09 0.07 ± 0.08 10.04 ± 1.23abc 7 0,13±0.19 0.02 ± 0.04 7.98±1.49abc
10 0.19 ±0.11 0.04 ± 0.07 27.58 ± 6.03ABC 10 0.31 ± 0.34 0.33 ± 0.54 15.95 ± 3.34abc
15 0.45 ±0.62 0.12 ±0.16 19.70 ±3.51abc 15 0.22 ± 0.28 0.25 ±0.17 23.06 ± 7.20abc
DPI lgG2b only IgE only lgG2b & IgE DPI lgG2conly IgE only lgG2c & IgE
0 0.38 ± 0.43 0.06 ± 0.09 2.32 ± 1 ,98ab 0 0.14 ±0.12 0.04 ± 0.06 1.86±1.87ab
1 0.25 ±0.14 0.20 ± 0.20 6.50 ± 2.25abc 1 0.25 ± 0.28 0.05 ±0.12 5.84 ± 1.75ABC
3 0.11 ±0.17 0.17 ±0.41 3.97 ± 2.03ab 3 0.19 ±0-31 0.35 ± 0.58 5.08 ± 1.39ab
5 0.00 ±0.00 0.00 ± 0.00 5.83±3.50ab 5 0.00 ± o.oo 0.00 ± 0.00 3.33±5.13ab
7 0.03 ± 0.05 0.03 ± 0.05 8.14±1,03abc 7 0.08 ± 0.09 0.01 ± 0.02 9.37 ± 1.25abc
10 0.15 ±0.12 0.27 ± 0.41 21.70 ± 4.95abc 10 0.08 ±0.20 0.14±0.18 21.33 ±4.56abc
15 0.46 ±0.89 0.05 ± 0.08 36.02 ± 7.67abc 15 0.25 ±0.46 0.48 ± 0.53 28.25 ± 14.30abc
Table 9 Summary of the means + standard deviations per field of 6 rats of the kinetics of appearance of
dual Ab, and single Ab expression by B cells in the PP-GC. A Indicates a significant increase in Ig-Debc
over the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @ p<0.05. c 
Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05. Significance was 
determined according to Newman-Keuls Multiple-Range Test.
Table 10: Two-Factor ANOVA Comparisons in the Germinal Center 
Regions of the Peyer's Patches
Two-Factor ANOVA:. Comparison of the Different Dual Ab- 
Expressing B Cell Combinations in the PP-GC
Source SS : tff , MS FP-value Fcrif
Dual-Ab Effect 206.97 5 41.39 2.71 <0.001 2.26
Day Effect 18927.9 6 3154.6 130.14 <0.0001 2.;14
Interaction 1618.83 30 53.96 2.23 <0.0001 1.51
Within 5090.53 210 24.24
Total 25844.2 251
Two-Factor ANOVA: Comparison Between lgA:lgE-Debc, 
IgA-Sebc, and IgE-Sebc in the PP-GC
Source SS df MS F P-value F crit
Ab Effect 3542.20 2 1771.1 275.14 <0.0001 3.08
Day Effect 844.81 6 140.80 21.87 <0.0001 2.19
Interaction 1812.17 12 151.01 23.46 <0.0001 1.85
Within 675.90 105 6.44
Total 6875.07 125
Two-Factor ANOVA: Comparison Between lgM:lgE-Debc, 
IgM-Sebc, and IgE-Sebc in the PP-GC 
Source SS df MS F P-value F crit
Ab Effect 3471,55 2 1735.6 111.47 <0.0001 3.08
Day Effect 1145.80 6 190.97 12.26 <0.0001 2.19
Interaction 2324.76 12 193.73 12.44 <0.0001 1.85
Within 1635.00 105 15.57
Total 8577.11 125
Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc, 
 lgG1-Sebc, and IgE-Sebc in the PP-GC 
Source SS df MS F P-value F crit
Ab Effect 2890.08 2 1445.0 357.11 <0.0001 3.08
Day Effect 1082.77 6 180.46 44.60 <0.0001 2.19
Interaction 2239.24 12 186.60 46.11 <0.0001 1.65
Within 424.88 105 4.05
Total. 6636.97 125
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Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc, 
lgG2a-Sebc, and IgE-Sebc in the PP-GC
Source SS df MS F P-value Fcrit
Ab Effect 2279.04 2 1139.5 166.24 <0.0001 3.08
Day Effect 634.77 6 105.80 15.43 <0.0001 2.19
Interaction 1383.13 12 115.26 16.82 <0.0001 1.85
Within 719.74 105 6.85
Total 5016.68 125
Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc, 
lgG2b-Sebc, and IgE-Sebc in the PP-GC
Source SS df MS F P-value F crit
Ab Effect 3919.23 2 1959.6 366.82 <0.0001 3.08
Day Effect 1824.44 6 304.07 56.92 <0.0001 2.19
Interaction 3653.90 12 304.49 57.00 <0.0001 1.85
Within 560.93 105 5.34
Total 9958.50 125
Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc, 
lgG2c-Sebc, and IgE-Sebc in the PP-GC
Source SS df MS F P-value Fcrit
Ab Effect 3082.55 2 1541.3 121.98 <0.0001 3.08
Day Effect 1177.86 6 196.31 15.54 <0.0001 2.19
Interaction 2492.91 12 207.74 16.44 <0.0001 1.85
Within 1326.68 105 12.64
Total 8079.99 125
Table 10. Two-factor ANOVA comparing the various Ab-expressing B cell 
combinations in the PP-GC of rats. The comparisons resulting in significant 
F values were then subjected to a Student-Newman Keuls test to determine 
any significant differences between groups. The values of p<0.05 were 
considered significant.
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3.6 Kinetics of the Appearance of 0X33 Labeled B Cells in the Small Intestine, Spleen,
Mesenteric Lymph Node, Peyer’s Patch-Non Germinal Center Regions, and Peyer’s
Patch-Germinal Center Regions:
To determine the total numbers of B cells in each of the organs and tissues 
examined, AO rats were infected with 2,000 Trichinella spiralis muscle larvae on day 0. 
Rats were randomly assorted into seven groups of six rats and tissues were taken from the 
small intestine 15cm distal to the pylorus, the nearest Peyer’s patches, mesenteric lymph 
node, and the spleen on days 0 (control), 1, 3, 5, 7, 10, and 15 after infection. Tissues 
were cryo-histologically processed and then labeled with monoclonal mouse anti-rat 
0X33 Ab conjugated with XRITC. The kinetics of the appearances of B cells were 
examined by immunofluorescence microscopy and the 0X3 3+ cells appeared bright red 
when using a 546nm filter as shown in Figure 32. The photographs are of samples from 
the MLN (A), spleen (B), PP-NGC (C), PP-GC (D), and small intestine (E) on day 15
after infection.
Samples of the small intestine labeled with monoclonal mouse anti-rat 0X33 Ab 
showed a significant increase in CD45RA+ B cells by day 3 of infection (7.57±2.15), as 
compared to the day 0 controls (0.52±0.76) (Fig. 33). The number of B cells 
continuously increased throughout the entire experiment, with the greatest number of B 
cells detected on day 15 after infection (31.87±5.72). B cells found in the spleen showed 
a much more delayed proliferative response to the Trichinella spiralis infection when 
compared to the small intestine. Significant increase in OX33+ B cells was found on day 
10 after infection (16.85±4.58) over the controls (6.04±1.64), with day 15 (22.58±5.20)
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being the peak day of proliferation (Fig. 34). MLN showed delayed proliferation of B
cells as well, with significant increase over the control (5.35±3.45) by day 5 after
infection (13.44+5.62) (Fig. 35). B cell proliferation continued in the MLN after day 5,
with a maximum amount found on day 15 after infection (29.41H2.66). The lowest degree 
of B cell proliferation was detected in the PP-NGC (Fig. 36). Significant increase over
the control (2.01 ±1.47) took place on day 5 (7.87+3.12), followed by a slight decrease on
day 7 (7.08+4.84) that was not significantly different from the control (Fig. 36). In this 
tissue, a significant increase in B cell number over the control occurred on day 10
(13.21+2.24), which was also the peak day of proliferation. The final tissue in which B
cells were enumerated was in the PP-GC. The PP-GC exhibited a high number of B cells
in the control (9.35+3.43), and infected rats showed a significant increase over the
controls on day 3 (18.23+4.94) (Fig. 37). Such significant proliferation maintained its 
kinetics throughout the remainder of the experiment with a maximum number of B cells 
quantified on day 15 (30.71+7.15). Significance for the number of OX 33 labeled B
cells, as compared to the controls, was determined using a one-factor ANOVA. 
Differences resulting in significant F values were the subjected to a Student Newman- 
Keuls multiple-range test and are presented in Table 11 and Table 12.
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Fig. 32 Appearance of CD45RA Positive B Cells Detected by 0X33 Ab in the Small 
Intestine, Spleen, MLN, PP-NGC, and PP-GC of Trichinella spiralis Infected Rats: 
Tissues were labeled with monoclonal mouse-anti-rat OX 33 Ab conjugated with XRITC, 
CD45RA+ B cells localized within a field [villus crypt unit (VCU) in the small intestine] 
from (A) MLN, (B) spleen, (C) PP-NGC, (D) PP-GC, and (E) small intestine were 
observed @ 400X magnification using a 546nm filter specific for viewing XRITC. The 
diameters of the labeled cells are between 10-12pm.
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Fig. 33 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33 
monoclonal Ab in the Small Intestine: Rats were infected with 2,000 Trichinella spiralis muscle 
larvae on day 0. Samples from the small intestine 15cm from the pylorus were removed on the
indicated days of infection and immunohistochemicaily processed to reveal CD45RA+ B cells in the 
small intestine. Data represents means + standard deviation per VCU of 6 rats per day.
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Fig. 34 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33
monoclonal Ab in the Spleen: Rats were infected with 2,000 Trichinella spiralis muscle larvae on
day 0. Samples from the spleen were removed on the indicated days of infection and
immunohistochemically processed to reveal CD45RA+ B cells in the spleen. Data represents means +
standard deviation per field of 6 rats per day.
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Fig. 35 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33 
monoclonal Ab in the MLN: Rats were infected with 2,000 Trichinella spiralis muscle larvae on day 
0. Samples from the MLN were removed on the indicated days of infection and immunohistochemically
processed to reveal CD45RA+ B cells in the MLN. Data represents means + standard deviation per 
field of 6 rats per day.
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Fig. 36 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33
monoclonal Ab in the PP-NGC: Rats were infected with 2,000 Trichinella spiralis muscle larvae on
day 0. Samples from the PP-NGC were removed on the indicated days of infection and
immunohistochemically processed to reveal CD45RA+ B cells in the PP-NGC. Data represents means
± standard deviation per field of 6 rats per day.
Days Post Infection
Fig. 37 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33
monoclonal Ab in the PP-GC: Rats were infected with 2,000 Trichinella spiralis muscle larvae on
day 0. Samples from the PP-GC were removed on the indicated days of infection and
immunohistochemicaily processed to reveal CD45RA* B cells in the PP-GC. Data represents means ±
standard deviation per field of 6 rats per day.
Numbers of CD45RA+ B Cells
Day Post 
Infection Sm. Intestine
Day Post 
Infection Spleen
Day Post 
Infection MLN
Day Post 
Infection PP-NGC
Day Post 
Infection PP-GC
0 0.52 + 0.76 0 6.04 ± 1.64 0 5.35 ± 3.45 0 2.01 ± 1.47 0 9.35 ± 3.43
1 4.33 + 2.09 1 6.70 ± 2.87 1 3.79 ±1.34 1 3.49 ± 2.02 1 10.43 ±3.58
3 7.57 ±2.15** 3 8.23 ±1.95 3 10.20 ±4.24 3 5.68 ± 3.02 3 18.23 ±4.94**
5 11.22 ±2.44** 5 3.94 ±1.81 5 13.44 ± 5.62** 5 7.87 ±3.12** 5 20.68 ± 6.95**
7 20.08 ± 5.62** 7 9.10 ±3.56 7 19.65 ± 8.73** 7 7.08 ±4.84 7 24.91 ± 5.77**
10 27.01 ± 2.99** 10 16.85 ±4.58** 10 24.77 ± 8.78** 10 13.21 ±2.24** 10 28.21 ± 5.56**
15 31.87 ±5.72** 15 22.58 ± 5.20** 15 29.41 ± 2.66** 15 10.89 ±4.59** 15 30.71 ±7.15**
Table 11 Summary of the mean ± standard deviations per field (per VCU in the Sm. Intestine) of 6 rats per day 
of the kinetics of appearance of CD45RA* B cells in the small intestine, spleen, mesenteric lymph node, non- 
germinal center regions of the Peyer's patches, and the germinal center regions of the Peyer's patches on days 
0 (control), 1, 3, 5, 7, 10, and 15 post infection. ** Indicates a significant increase over the control groups @ 
p<0.05 for each tissue. Significance was determined according to the Newman-Keuls Multiple-Range Test.
Table 12: One-Factor ANOVA Comparisons for 0X33 Labeled B Cells in 
the Small Intestine, Spleen, MLN, PP-NGC, and PP-GC
One-Factor ANOVA: Total B Cell Count in the Small Intestine 
Through OX33-Ab labeling
Source SS df MS F P-value F crit
Day Effect 5081.34 6 846.89 65.81 <0.0001 2.37
Within Groups 450.42 35 12.87
Total 5531.77 41
One-Factor ANOVA: Total B Cell Count in the Spleen 
Through OX33-Ab labeling
Source SS df MS F P-value Fcrit
Day Effect 1624.53 6 270.76 24.06 <0.0001 2.37
Within Groups 393.82 35 11.25
Total 2018.35 41
One-Factor ANOVA: Total B Cell Count in the MLN Through 
OX33-Ab labeling
Source SS df MS F P-value F crit
Day Effect 3410.75 6 568.46 17.78 <0.0001 2.37
Within Groups 1118.81 35 31.97
Total 4529.57 41
One-Factor ANOVA: Total B Cell Count in the PP-ngc 
Through OX33-Ab labeling
Source SS df MS F P-value Fcrit
Day Effect 559.13 6 93.19 8.75 <0.0001 2.37
Within Groups 372.63 35 10.65
Total 931.76 41
One-Factor ANOVA: Total B Cell Count in the PP-GC Through 
OX33-Ab labeling
Source SS df MS F P-value Fcrit
Day Effect 2482.69 6 413.78 13.62 <0.0001 2.37
Within Groups 1063.34 35 30.38
Total 3546.03 41
Table 12. One-factor ANOVA comparing CD45RA* B cells labeled with 0X33- 
Ab in the small intestine, spleen, MLN, PP-NGC, and PP-GC for respective 
days of infection in rats. The comparisons resulting in significant F values were 
then subjected to a Student-Newman Keuls test to determine any significant 
differences between groups. The values of p<0.05 were considered significant.
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4) Discussion
B-lymphocytes proliferating in the small intestine of rats against Trichinella 
spiralis infection have been shown to produce nearly all Ab isotypes at some point during 
infection. Bell et al. (1992) showed that three isotypes of IgG (IgGl, IgG2a, and IgG2c) 
in rats were actively produced by B cells against this infection. Other groups have shown 
drastic increases of IgA (Van Loveren et al., 1988; Brown et al., 1989), or high increases 
of IgE (Wang et al., 1998; Negrao-Correa et al., 1996) against the same parasite. Based 
on recent findings (Wang et al., 1998; Wang et al., 1999), it was shown that IgE- 
producing B cells produced the strongest response against the 9D4 antigen of Trichinella 
spiralis. Therefore, IgE was used as a common Ab label for testing the dual Ab 
expression on B cells in this experiment. Quantitative examination of dual Ab-bearing B 
cells and single Ab-expressing B cells from the small intestine, spleen, mesenteric lymph 
node, Peyer’s patch germinal centers, and Peyer’s patch non-germinal centers of 
Sprague-Dawley rats are reported in this thesis. Among the different Ab isotypes tested 
using a double-labeling immunofluorescence assay were IgA, IgM, IgGl, IgG2a, IgG2b, 
or IgG2c, respectively, combined with the common IgE Ab. A separate
immunofluorescence assay was also carried out to quantify total B cell numbers within 
the same tissues to examine the possibility that B cells in rats may be expressing multiple 
Ab isotypes on the surface during Trichinella spiralis infection.
A significant increase in the expression of two Ab isotypes on the surface of B 
cells over the controls and the single Ab-expressing B cells in the non-Peyer’s patch 
region of the small intestine occurred as of day 3 post infection for all of the isotypes
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tested (Fig. 2-7). This shows that B cells are being activated to proliferate and produce 
Ab in the small intestine very early after infection with Trichinella spiralis. Most B cells 
become activated to undergo clonal proliferation through interactions with T helper cells, 
and Wang et al. (1990) showed that intestinal T cells are actually activated as early as 12 
hrs post infection with the same parasite. Therefore, this indicates that it takes less than 2 
days for the intestinal T cells to activate B cells in the intestine. These B cells then 
immediately start expressing many Ab isotypes on the surface and most likely are 
secreting these Ab into the mucosal tissues. A very small population of B cells in the 
controls of the intestinal villi was found (Fig. 2-7 and Fig. 33). As the infection was 
prolonged, the B cells seemed to actively proliferate in this area at a rapid rate when 
compared to other lymphoid tissues. The concentration of B cells per villus crypt unit of 
the small intestine was higher than those found per field in all of the lymphoid tissues 
studied (Fig. 2-31). This drastic kinetic augmentation shows that the B cells, which are 
present in the villi of the small intestine, are actively proliferating to fight off the 
infection even before the other surrounding lymphoid tissues are showing signs of B cell 
activation. Therefore the nonlymphoid region of the small intestine does have an 
enormous capability to mount an effective immune response against Trichinella spiralis
infection.
Similar effects on activation were seen in the lymphoid tissues as well, but it was 
a somewhat delayed B cell proliferative response and also with less concentration of B 
cells as was found in the non-lymphoid region of the small intestine. Within the non- 
germinal center region of the Peyer’s patches, there was a relatively low rate of
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proliferation with a significant increase only 7 days after infection (Fig. 20-25). Most of 
the B cell proliferation in the Peyer’s patches occurred within the germinal center region. 
This is believed to be the location where most of the B cell proliferation is normally 
occurring, and therefore is likely the reason for the higher number of Ab-expressing B 
cells in this area found in this study (Fig. 26-31). Within the germinal centers, a high 
number of Ab-expressing B cells was identified, with variable significant rates of Ab- 
expressing B cells first found from day 5 for IgAJgE-Debc to day 7 for the other Ab 
isotypes (Fig. 26-31). The kinetics of dual Ab-expressing B cell proliferation in this 
region was delayed somewhat compared to that of the small intestinal villi, but the total 
number of B cells seemed to be comparable on the peak days of infection. The difference 
was that germinal centers of the controls showed a relatively high number of Ab- 
expressing B cells which was nearly six times greater than that found in the small 
intestinal villi (Fig. 2-7 and Fig. 26-31). As infection proceeded the B cells were likely 
shunted toward the villi of the small intestine from the germinal centers, as well as active 
proliferation of the B cells within the villi which would account for the rapid 
augmentation in these Ab-expressing B cells within this area.
MLN and the spleen were also delayed in the appearance of proliferation of dual 
Ab-expressing B cells to Trichinella spiralis infection (Fig. 8-19). This delayed response 
was expected because these tissues would be among the last to receive any signal of 
infection within the small intestine. MLN is the lymphoid tissue that drains the lymph 
derived from the Peyer’s patch and the small intestine, so the activated T cells and/or B 
cells would have to migrate into this area before a local activation could occur. Since the
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initial activation of the Th cells and the dual Ab-expressing B cells is in the small 
intestine, the B cells within the MLN would naturally show delayed response to this 
intestinal infection until activated T cells and/or Ab-expressing B cells from the small 
intestine are diverted into this region. The spleen is a major organ of the systemic 
lymphatic system, and therefore activated Th cells and/or the dual Ab-expressing B cells 
from the local mucosal region of the small intestine would have to become systemic and 
spread before activation could occur within this area. Another possible reason for the 
delayed response within theses two lymphoid tissues could be related to the reproduction 
and systemic migration of Trichinella spiralis new bom larvae (NBL). As the larvae 
disseminate out of the small intestine to the various tissues of the body, activation of new 
B cells would occur. Similarly the intestinal parasite could also secrete Ag which could 
be drained into the systemic circulation. Such Ag could in turn stimulate the MLN, 
spleen, and other lymphoid tissues, and then lead to a generation of a humoral immune
response.
Within the different tissues examined throughout the duration of the experiment, 
it was found that B cells expressed all of the different Ab isotypes. In the villi of the 
small intestine (Fig. 2-7), spleen (Fig. 8-13), MLN (Fig. 14-19), and non-germinal center 
regions of the Peyer’s patches (Fig. 20-25), no significant quantitative differences 
between the numbers of B cells expressing different dual Ab-isotypes were revealed 
during each day after infection. Therefore these results suggest that these B cells are 
being activated to synthesize all of the different Ab isotypes to fight off the Trichinella 
spiralis infection in both the lymphoid and the nonlymphoid tissues. This makes sense
93
because in theory, the greater the variety of a response to a specific Ag, the greater the 
chance of destroying the Ag before extensive damage occurs. So the more variety of Ab 
that is produced against Trichinella spiralis, the more effective the immune response 
should be. In the germinal center regions of the Peyer’s patches all of the different 
isotypes were also expressed by B cells, but different isotypes were detected at different 
times throughout the infection (Fig. 26-31). In the controls there was a higher number of 
IgA- and IgM-expressing B cells, but as the infection took place and proceeded through 
time, similar quantities of the Ab-expressing B cells were found as compared to that of 
other Ab-expressing B cells (Fig. 26-27). This shows that under normal conditions, the 
Peyer’s patch germinal centers produce B cells that mostly express IgA and IgM, which 
confirms many previous studies (Van Loveren et al., 1988; Brandtzaeg, 1996; Ehrhardt et 
al., 1996). However, once an infection of Trichinella spiralis occurs, B cells are quickly 
stimulated to lead to various Ab isotypes being expressed. Although IgE-expression was 
not measured alone in the tissues of this experiment, it was found in high amounts on the 
dual Ab-expressing B cells that would show that it was also being actively produced by B 
cells against this parasite (Fig. 2-31). Most mucosal B cell research revolves around IgA 
production within the Peyer’s patches of the small intestine (Kawanishi et al., 1983; 
Spencer et al., 1986; Homquist et al., 1995), but in this experiment it was shown that 
there were B cells expressing all of the different isotypes after infection with Trichinella 
spiralis. It has also been shown that IgA is not the only isotype produced, and that IgA 
does not even appear to be the major isotype produced against this infection in any of the 
four tissues tested. As would be expected from a parasitic infection, and from previous
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studies (Wang et al., 1998; Negrao-Correa et al., 1996), IgE would appear to be the major 
single Ab produced by B cells against Trichinella spiralis. In this experiment though, all 
of the other Ab isotypes are also expressed in similar high quantities to that of IgE as 
well. Therefore no single Ab isotype produced by B cells dominated any other isotype 
against this infection.
The various Ab isotypes expressed by B cells were demonstrated through the use 
of double labeling of the B cells for two Ab isotypes. In the small intestine significant 
increase of dual Ab-expression of B cells first occurred on day 3 after infection with 
Trichinella spiralis, and the peak days were on days 7 and 10 (Fig. 2-7). Based on the 
amount of dual Ab-expressing B cells that were counted per villus on average (between 
21.26±4.71 and 29.01±3.87) for each of the dual Ab-labeled combinations, it would 
appear that each villus would become overwhelmed with B cells alone and not leave any 
space for other cells of the immune system to function. For this reason a total B cell 
count, using 0X33 monoclonal Ab to label CD45RA found only on B cells in rats, was 
taken to determine the quantities of B cells within each villus. For the controls and the 
first 3 days post infection, no differences were found between the total number of B cells 
and the total number of dual Ab-expressing B cells for each of the combinations. When 
calculating and adding all of the different combinations of dual Ab-expressing B cells for 
each of the peak days post infection (day 7 and day 10) (Fig. 2-7), the average number of 
dual Ab-expressing B cells per VCU considerably outnumbered that of the expected total 
B cell numbers from the 0X33 labeled cells (Fig. 33). The total dual Ab-expressing B 
cells on day 7 after infection was more than 7 times that of the detected total number of
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OX33-labeled B cells (Fig. 33). Dual Ab-expressing B cells on day 10 post infection
when combined was over 5 times that of the actual total number of B cells revealed
through 0X33 labeling (Fig. 2-7 and Fig. 33). This indicates that these B cells are not 
only expressing two Ab isotypes on the surface as was shown, but are most likely 
expressing more than just the two isotypes of Ab during Trichinella spiralis infection. 
This phenomenon could lead to a greater variation in response to the Trichinella spiralis 
Ag, and a much more rapid expulsion of the parasite from the rat intestine. As of day 15 
after infection, the total number of dual Ab-expressing B cells combined in the small 
intestine on average was < 3 times over that of the 0X33 labeled B cells. This decreasing 
tendency of possible multiple Ab-expressing B cells in the non-Peyer’s patch regions of 
the small intestine from the peak day 7 through day 15 is most likely due to an increase in 
B cells that have been switched to single Ab-expressing B cells again. Another reason 
for this reduced number of possible multiple Ab-producing B cells could be from the 
production of memory B cells as the infection is prolonged.
The same kinetics of appearance of B cells seen in the small intestine was also 
present in the lymphoid tissues, with the B cells being shown to express dual Ab isotypes 
on the surface. When comparing the dual Ab-labeled B cells of the various lymphoid 
tissues to the 0X3 3-labeled B cells in these tissues, our data suggests more than two 
isotypes being expressed on the surface of B cells. This not only confirms what was 
found in the nonlymphoid region of the small intestine, but also strengthens the theory 
proposed above that these dual Ab-expressing B cells are synthesizing more than just two 
isotypes at any particular point in time. The difference of 0X3 3+ B cells in the lymphoid
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tissues was similar to that found in the proliferation of the Ab-expressing B cells, which 
mustered delayed response to the Trichinella spiralis infection compared to that of the 
nonlymphoid region of the small intestine. No significant increase in the number of dual 
Ab-expressing B cells was noticed in the spleen or in the mesenteric lymph node until 
days 10 and 15 after infection (Fig. 8-19). The number of dual Ab-expressing B cells in 
the spleen peaked on day 10 which was greater than 6 times higher than the total 0X33- 
labeled B cells, and the ratio dropped to less than 3 times on day 15 (Fig. 8-13). In the 
MLN, the number of dual Ab-expressing B cells was only about 3 times higher on day 10 
where as it was less than twice the amount of the 0X33 labeled B cells on day 15 (Fig. 
14-19). This demonstrates that the B cells in the MLN and spleen are possibly expressing 
more than two Ab isotypes on the peak days of B cell proliferation, but during most of 
the infection they are expressing only up to two isotypes. This was remarkably different 
from what was found in the small intestine. It is most probable that a major portion of 
the activated dual Ab-expressing B cells in the spleen and MLN result from differentiated 
B cells or from new dual Ab-expressing B cells that arrived from the small intestine. 
These activated B cells could have also been a result from NBL that migrated to these 
tissues, or were activated by parasitic Ag that arrived in these tissues during the process
of infection. If activated T cells and/or B cells from the small intestine were drained into
one of the lymphoid tissues, then proliferation could result within these areas as well.
97
Dual labeled B cells in the non-germinal center region of the Peyer’s patch though 
present, remained relatively low throughout the entire experiment (Fig. 20-25) so when 
comparing these cells to the 0X33 labeled cells (Fig. 36) no multiple expression could be 
determined. To the contrary, the germinal centers of the Peyer’s patch demonstrated 
much more similar kinetics of the numbers of dual Ab-expressing B cells to that of the 
villi in the small intestine. On day 7 the compiled count of dual Ab-bearing B cells was 
greater than 2 times that of the total B cells quantified using the 0X33 labeled cells. 
Within the PP-GC however, there was a steady increase of double labeled B cells through 
day 10, which was just less than 5 times greater than the 0X33 labeled cells, and day 15 
of greater than 5 times that of the 0X33 labeled B cells (Fig. 26-31 and Fig. 37). These 
results show that the B cells in the PP-GC are also conceivably producing multiple Ab 
isotypes by day 7 post infection. The number of dual Ab-expressing B cells in the PP- 
GC though is less than that found in the non-Peyer’s patch region of the small intestine 
and the dynamics of appearance of these B cells is also more delayed. So the dual- 
labeled B cells in the small intestine are likely activated to proliferate within this 
normally nonlymphoid region without the need from B cells in the Peyer’s patches 
migrating into this region. Based on the results, these intestinal B cells are possibly 
producing more Ab than just the two tested for in the lamina propria of the small
intestine. '<
Most studies involving B cells research focus on B cells producing one Ab 
isotype at a time only. There have been only few studies involving dual-labeled B cells 
(Chen et al., 1986; Karttunen et al., 1991; Goodman et al., 1997), and no studies to date
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on the possible expression of multiple Ab isotypes by B cells. In this study, activated B 
cells expressing dual Ab isotypes on the surface were stimulated by Trichinella spiralis 
and were identified and quantified using the double-labeling immunofluorescence assay. 
Based on the results presented here, it appears that these B cells most likely express 
multiple isotypes. This strongly suggests that in these intestinal B cells, there is 
tremendous RNA splicing activities following Trichinella spiralis antigenic stimulation 
and activation of T helper cells. DNA gene rearrangement and recombination events may 
also occur, but at a much lower rate as indicated by the extreme low level of single­
isotype expressing B cells in these tissues. Other studies using different cell lines in vitro 
have also suggested RNA splicing in mouse (Shimizu et al., 1991; Wu et al., 1991) and 
human cells (Akahori et al., 1990; Caldwell et al., 1991; Nolan-Willard et al., 1992), but 
future research is needed to determine if RNA splicing mechanisms also occur in rats. 
Further research is also needed in this area to determine if this mechanism occurs in vivo, 
and allows for B cells to produce more than two Ab isotypes during Trichinella spiralis
infection.
A possible problem that may have skewed some of the results of this research is 
that of Ab binding to FcR of cells involved in the nonspecific immune responses.
Neutrophils, eosinophils, basophils, and M<j) were not tested for in this study at any point
during infection. B cells could have secreted out Ab which in turn bind to the FcR of
these cells. Ab probes that were used would then bind to the Fc region of the Ab 
connected to the cells FcR and fluoresce, thereby giving a positive signal as being an Ab- 
expressing B cell. This occurrence though was conceivably extremely minimal, because
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most nonspecific cells in rats have only been shown to express one type of FcR on the 
surface, or were not consistent with the dual-Ab tested for. Neutrophils have FcR for IgG 
and IgA (Isashi et al., 1995), but has not been found to bind IgE. Eosinophils and 
basophils express FcR only for IgE (Alber et al., 1992), and M<j> only subtypes of IgG 
(Ravetch, 1991). These cells would then only allow for an increase in the number of 
single Ab-expressing cells, which remained very low in all of the tissues throughout the 
experiment. The only exception found to date is that of mast cells that have the 
capability of expressing FcR for IgE and IgG2a in rats (Alber et al., 1992). In other 
experimental systems such as mouse and human, FcR specific to more Ab isotypes have 
been shown (Unkeless et al., 1988; Takizawa et al., 1992; Ravetch, 1991). Studies with 
multiple fluorescent markers, or using the fluorescent activated cell sorter analysis to 
count the various B cells would make the procedures much more accurate and also 
involve much less time. Currently, the state-of-the-art technology could allow for the 
detection of three fluorescent markers simultaneously, but in this experiment access was 
limited to only two different markers. This would allow for more extensive studies and 
more conclusive results as to the theory of multiple Ab production by B cells. Future 
experiments to determine the specific gene rearrangement of the Ab within these various 
B cells, and to determine if RNA splicing of the new Ab is the mode of synthesis of Ab 
could also aid in the better understanding of multiple expression of B cells.
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